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Abstract 
 
Albinism is an inherited congenital disorder which occurs in humans with a prevalence of 
around 1 in 20,000 and is linked to a disruption of melanin synthesis or transport. 
Associated with this disorder is a significant hypopigmentation, primarily of skin, hair and 
the eye, but also of parts of the brain. This hypopigmentation has various effects on the 
morphology and function of the eye and the brain. It affects, among others, the iris, retinal 
pigment epithelium and macular differentiation, Nervus Opticus, visual acuity, chiasmal 
crossings, binocular vision, fixation and nystagmus, refraction and cerebral maturation. 
In patients affected by albinism, the treatments of eye-related disorders vary and can 
range from surgical intervention to milder forms of treatment. Early Intervention (EI) is a 
general term which subsumes various supportive, non-invasive therapies for children 
aiming to improve their quality of life. These strategies are known as “Fruehfoerderung” in 
German, and appear in the Anglo-Saxon medical literature under various names, besides 
‘Early Intervention’ also as ‘visual stimulation’, ‘visual learning’ etc. 
As part of the study, the specific impact of EI on visual acuity has been considered. 
Relevant data has been obtained from the Archive of the Department of Ophthalmology of 
the University Hospital of Saarland, and the visual acuity of a cohort of children aged 6 to 
15 (test group, n = 232) has been compared to the one of a control group of patients aged 
over 25 (control group n = 139), who have not received EI.  
The statistical analysis conducted as part of this thesis points towards a slight yet 
statistically insignificant improvement of visual acuity in girls who have received Early 
Intervention. This slight improvement of around 0.1 visual units is notably absent in boys. 
Further analysis has confirmed that this small improvement is not due to a generally better 
visual acuity in females, as no enhanced visual acuity could be seen in the females of the 
control group when compared to the corresponding males. 
Nonetheless, even this small improvement of the visual acuity in the females of the test 
group is weak when considered on a scale from 0 to 1. Macular and optical nerve 
pathologies correlate significantly to visual acuity. The more severe such pathologies are, 
the worse the visual acuity is. 
As the statistical analysis employed as part of this study only considers cohorts of 
patients, but cannot monitor the changes of visual acuity on an individual basis, it is 
possible that some patients with a particular predisposition may be more amenable to 
treatment by EI than others. Such individual effects ‘disappear’ in a cohort-based analysis 
but may be relevant. Indeed, not all patients in the two respective cohorts show similar 
visual acuities, and the statistical spread is considerable. Future studies should therefore 
investigate the impact of EI on a more personal basis, for instance by monitoring 
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improvements of visual acuity on an individual basis, during EI and in form of a close 
follow-up during the subsequent years. At the same time, the question of ‘responders’ 
and ’non-responders‘ is of major importance for a possible treatment and prognosis and 
should be addressed by accompanying biochemical and possibly even genetic analyses. 
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Kurzfassung 
 
Albinismus ist eine erbliche, kongenitale Veränderung, die beim Menschen mit einer 
Häufigkeit von etwa 1 in 20.000 auftritt und mit einer gestörten Synthese von Melanin oder 
einem gestörten Melanin-Transport in Verbindung steht. Hypopigmentation geht mit dieser 
Störung einher und betrifft primär die Haut, Haare und das Auge, aber auch Teile des 
Gehirns. Hypopigmentation wirkt sich auf verschiedene Weise auf die Morphologie und 
Funktion des Auges und Gehirns aus. Es betrifft unter anderem die Iris, das retinale 
Pigment Epithelium und die makulare Differentiation, den Nervus Opticus, die Sehschärfe, 
chiasmale Kreuzungen, binoculare Sehweise, Fixation und Nystagmus, Refraktion und 
cerebrale Entwicklung. 
Bei Patienten mit Albinismus variiert die Behandlung von Beeinträchtigungen des Auges 
und reicht dabei von einem chirurgischen Eingriff bis zu milderen Formen der 
Behandlung. Der Ansatz der visuellen Frühförderung (FF) subsummiert dabei 
verschiedene unterstützende, nicht-invasive Therapien für Kinder, die auf eine 
Verbesserung der Lebensqualität abzielen. Diese Strategien finden sich in der 
anglosächsischen Literatur unter Bezeichnungen wie „Early Intervention“ (EI), „visual 
stimulation“ oder „visual learning“ wieder. 
Als Teil dieser Studie ist der besondere Einfluss der visuellen FF auf die Sehschärfe 
untersucht worden. Die entsprechenden Rohdaten sind dabei aus dem Archiv der 
Augenklinik des Universitätsklinikums Saarland bezogen worden. Die Sehschärfe einer 
Gruppe von Kindern im Alter von 6 bis 15 Jahre (Test-Gruppe, n = 232) ist dann mit der 
Sehschärfe der Kontrollgruppe von Patienten über 25 Jahren verglichen worden (n = 
139), die keine FF erhalten hatten. 
Die als Teil dieser Arbeit durchgeführte statistische Analyse weist auf eine geringe, aber 
statistisch nicht signifikante Verbesserung der Sehschärfe bei Mädchen mit FF hin. Diese 
geringe Verbesserung von etwa 0,1 Messstufen (Zeilen) fehlt interessanterweise bei den 
Jungen. Eine weitere Analyse der Daten hat ergeben, dass diese geringfügige 
Verbesserung nicht auf einer generell besseren Sehschärfe bei Frauen beruht, da bei den 
Frauen in der Kontrollgruppe im Vergleich zu den entsprechenden Männern keine bessere 
Sehschärfe ermittelt werden konnte. 
Letztendlich fällt diese kleine Verbesserung der Sehschärfe bei den Patientinnen in der 
Test-Gruppe auf einer Skala von 0 bis 1 aber sehr gering aus. In diesem Fall dominieren 
letztendlich Pathologien, wie Veränderungen der Iris, der Makula und des Sehnervs, die 
auch signifikant mit der Sehstärke korrelieren. Je dramatischer solche Pathologien sind, 
desto schlechter ist die Sehschärfe. 
Da die in der Arbeit verwendete statistische Analyse allerdings lediglich Gruppen von 
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Patienten betrachtet - und daher individuelle Veränderungen der Sehschärfe außer Acht 
lässt - ist es durchaus möglich, dass manche Patienten mit einer gewissen Prädisposition 
besser auf eine Behandlung mit FF reagieren als andere. Solch individuelle 
Besonderheiten „verschwinden“ bzw. gehen in einer Gruppen-basierenden Analyse quasi 
in der Menge unter, können jedoch relevant sein. In der Tat zeigen nicht alle Patienten in 
den beiden entsprechenden Gruppen jeweils ähnliche Sehschärfen und die statistische 
Streuung ist erheblich. Zukünftige Studien sollten daher die Auswirkung von FF eher mit 
Hinblick auf einzelne Patienten untersuchen, beispielsweise durch eine Beobachtung der 
Verbesserung der Sehschärfe auf individueller Basis, während der FF und anhand einer 
umfassenden Nachbetreuung in den darauffolgenden Jahren. Zugleich ist der Umstand, 
dass gewisse Patienten auf die Behandlung ansprechen, und andere nicht, von großer 
Bedeutung sowohl für die Therapie als auch für die Prognose und sollte daher von 
begleitenden biochemischen und womöglich sogar genetischen Studien näher beleuchtet 
werden. 
  
Early Intervention in Albinism 
8 
Acknowledgements 
 
First and foremost, I would like to express my sincere gratitude to the Head of the 
Department of Ophthalmology of the University Hospital of Saarland, Prof. Dr. med. 
Berthold Seitz, for accepting me as one of the Department’s MD students and for his 
continuous support during the entire processes leading to this dissertation. 
 
My special thanks, of course, go to my MD supervisor, Prof. Dr. med. Barbara Käsmann-
Kellner, for presenting me with such a stimulating topic and her endless help and support 
during my research and writing the thesis. This work would not have been possible 
without her. 
 
Digging for data in the basement of the Department also known as “archive” has never 
been an easy task, and I greatly appreciate the friendly atmosphere and support of the 
staff of the Section of Paediatric Ophthalmology and Low Vision, especially Mrs. Köhler, 
Mrs. Müller and Mrs. Lauer. 
 
I would also like to thank Ms Javeria Ifthikar PharmD for introducing me to the wonderful 
and often complex world of modern-day statistics in general and the use of the statistics 
software programme SPSS in particular. 
 
Many thanks also to Dr. Torsten Burkholz for helping me with the intricate pathway of 
melanin biosynthesis. 
 
And finally, on a more personal note, I would like to thank my family, especially my 
husband Claus and my children Eric and Elizabeth for their patience and understanding, 
especially during the many fruitless and sometimes entirely foodless weekends dedicated 
to this thesis. 
Early Intervention in Albinism 
9 
1. Albinism: A short introduction 
 
Albinism is an inherited congenital disorder which occurs in humans with a prevalence of 
around 1 in 20,000 (Käsmann-Kellner et al. 2007). In some parts of the world, such as 
Africa, the prevalence is even somewhat higher (e.g. 1 in 10,000). Albinism is the result of 
disrupted or reduced melanin biosynthesis or deficient transportation (see below). Hence, 
persons with albinism are characterized by a distinct lack of melanin, which sometimes 
results in a range of obvious features, such as white skin, white hair and also absence of 
pigment in the eyes. Interestingly, albinism is not limited to humans but also occurs in all 
mammals, and “albino” rats, for instance, are well known and liked as pets (Figure 1). 
 
From a scientific point of view, albinism is a rather complex issue which combines various 
aspects ranging from the genetics of inheritance and melanin biosynthesis to 
ophthalmological issues and, in some extreme cases, even social rejection. Before 
moving on to more clinical matters, it is therefore necessary for our understanding of this 
matter to briefly consider these genetic, biochemical and social aspects first. 
 
 
 
 
 
 
 
 
 
Figure 1.1: Picture of two normally pigmented (left) and an albinistic guinea pig (right). 
The white fur and red eyes are clearly visible. Whilst some normal guinea pigs may also 
be almost while, pigmentation may be present in patches and the eyes are black (left). 
Animals and photos are kindly supplied by Elizabeth Louise Jacob. 
 
In short, albinism is a multi-facetted inheritable condition based on specific genetic 
alterations with an associated, changed biochemistry, notably the one surrounding the 
pigment melanin. Albinism sometimes results in a specific phenotype with diverse 
characteristics which have an impact on the individual’s visual sensory abilities and in 
some cases on her or his neuropsychiatric health. In addition, such changes and “unusual 
looks” in general terms may also raise issues of a more social nature. Here, a particular 
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sensitivity of skin towards sunlight and often impaired eyesight are perhaps the most 
significant issues affecting persons with albinism. Such sensitivities obviously demand 
specific precautions and types of behaviour (especially with regard to exposure to 
sunlight) which are not necessary for persons with normally pigmented skin or eyes. 
These individual layers of albinism from basic genetic changes to social behaviour will 
now be addressed briefly starting with the basic genetic aspects. 
 
 
1.1. Genetic aspects of albinism 
 
From a genetic point of view, albinism is not just a single disorder due to one specific mu-
tation. It rather represents a group of slightly different recessive disorders, each with one 
(or several) particular mutations in the melanin biosynthesis or transport pathway. Most of 
these forms are related to autosomal recessive alleles which have to be passed on from 
both parents (see below). 
 
As the various forms of albinism are recessive traits, the idea that albinism is an inherita-
ble disorder is far from obvious, as it also “appears” in children of seemingly non-albinistic 
parents. Historically, the notion of albinism as an inheritable disorder therefore dates back 
to the beginning of the 20th Century, and hence to the beginnings of modern genetic re-
search. W.C. Farabee, in 1903, was the first to suggest that albinism in humans could be 
considered a recessive trait, which was confirmed later on by more extensive studies con-
ducted by W.E. Castle and colleagues (Farabee 1903, Castle 1903). As a consequence of 
the recessive nature of this trait, the chance of inheriting albinism is comparably low and, 
as already mentioned, albinism occurs despite the fact that both parents are seemingly 
non-albinistic. 
 
Indeed, according to the genetics of inheritance - which dates back to Gregor Mendel 
(1822-1884) and the mid 19th Century - a recessive trait is defined as a particular pheno-
typical property A, which is passed on to the offspring only if both parents possess one 
allele bearing the genetic information of his trait (without, however, necessarily also show-
ing this phenotype). In contrast to a dominant trait, recessive traits are therefore passed 
on to the next generation rather infrequently. Yet in contrast to dominant traits, the pheno-
type A may be passed on from non-A parents, i.e. from parents who do not show this par-
ticular phenotype. Hence albinism may occur in children of parents which both are not 
albinistic, and therefore for the layman also rather “surprisingly”. 
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Whilst these considerations apply to albinism in general terms, albinism is not a simple 
‘one mutation’ issue. At closer inspection, it becomes apparent that different forms of 
albinism exist which are associated with different kinds of mutations (see 1.2.). Eventually 
it has been shown that all forms of albinism are autosomal recessive with the exception of 
ocular albinism (OA), which is X-linked recessive and linked to a single gene, OA1 
(Oetting et al. 1999). The OA1 gene is located on chromosome Xp22.32. A total of 25 
missense, two nonsense, nine frameshift and five splicing mutations have been found in 
the OA 1 gene (Oetting 1998). As OA is passed on through X-linked inheritance, this kind 
of albinism is usually found in male patients. The prevalence of OA in males can be 
explained by considering genetics: Males possess a XY set of chromosomes (21st 
chromosome pair) and their Y chromosome cannot ‘compensate’ for an inheritable trait 
present on their X chromosome, whilst females have two X chromosomes and their 
‘unaffected’ X chromosome can compensate for the mutation of the affected one (bearing 
in mind, of course, that the trait is recessive). 
 
Other types of albinism, i.e. oculocutaneous albinism (OCA), are genetically more 
complex due to various distinct mutations on different genes and chromosomes. To date, 
14 different genes in ten chromosomes (not including the X chromosome) have been 
identified which are associated with different types of OCA. These forms of OCA are 
briefly summarized in Table 1 (Cortes et al. 2005, Oetting et al. 2005, Rundshagen et al. 
2002, Käsmann-Kellner et al. 2007, Hedge et al. 2002, Fitzpatrick et al. 1974). It should 
be noted that this classification is based on a rather detailed genetic analysis and as a 
consequence is generally open to future changes and additions. 
 
Based on genetic considerations, oculocutaneous albinism (OCA) itself is divided into four 
forms (see Table 1). Whilst it is difficult to clinically distinguish these forms by phenotype 
alone, they differ by their distinct mutations in different proteins or enzymes (see 1.2.). 
Therefore genetic analysis is a highly useful tool in the precise diagnosis of the specific 
type of albinism (Zühlke et al. 2007). At closer genetic inspection, Zühlke et al. have found 
genetic variations in 70 % of a large German cohort of albinism patients. Most of these 
(German) patients exhibit OCA1 with mutations in the tyrosinase gene, whilst other, 
slightly milder forms (OCA2 - OCA4) result from mutations in genes which affect the 
processing of this enzyme or trafficking to the melanosomes (Costin et al. 2003, Toyofuku 
et al. 2010). Here, it should be noted that OCA2 - and not OCA1 - is the most frequent 
form of albinism worldwide as it is most prevalent in countries and continents with a high 
rate of consanguineous parents. 
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Importantly, whilst OCA1 is related to mutations in the tyrosinase gene, such mutations 
are not necessarily identical in all individuals with OCA1. An analysis of OCA1 patients 
has surfaced DNA variations in 82 unrelated individuals, and these variations include 68 
single nucleotide changes, stop mutations, polymorphisms, four nucleotide insertions and 
six deletions (Opitz et al 2004). In any case, tyrosinase, a key enzyme in the melanin 
synthesis, is affected by these various mutations.  
 
Type of 
Albinism 
Genetic Location Dysregulation of 
Melanin Synthesis 
Subgroups and 
Syndromes of 
Hypopigmentation 
OCA1 Mutations in 
tyrosinase gene 
11q14-q21 
Blockage of pigment 
formation 
OCA1A tyrosinase 
completely blocked 
OCA1B tyrosinase 
incompletely active 
OCA1TS temperature-
sensitive activity of 
tyrosinase 
OCA2 Mutations in P-gene 
15q11.2-q12 
Formation of Melano-
soms “P”: “pink eye-
dilution gene” transport 
OCA2 
Prader-Willi-Syndrome 
PWS 
Angelman-Syndrome AS 
Griscelli-Syndrome GS 
Type1-3 
OCA3 Mutations in TYRP-
1-gene 
9p23 
Stabilization  of 
melanosoms 
(“tyrosinase related 
protein 1”) 
OCA3 
so-called “Red Albinism” 
OCA4 Mutations in MATP-
gene 
5p13.3 
Transport (membrane 
associated transport 
protein) 
rare in Europe, more 
common in Asia 
Hermansky-
Pudlack-
Syndrome 
22q11.2-
q12.2,19q13,11p15-
p13, 
10q24.32, 10q23.1, 
6p22.3,3q24 
Formation of melano-
soms, biogenesis of 
lysosoms 
HPS Types 1-8 
Genetically very 
heterogeneous 
Chediak-
Higashi-
Syndrome 
1q42.1-q42.2 Formation and size of 
melanosoms 
very rare 
OA1(OA-X) Xp22.3 Biogenesis of 
melanosoms, signal 
transduction 
Ocular Albinism Type 1 
 
Table 1.1: Molecular genetic types of albinism, their genetic location and resulting 
dysregulation of intracellular processes (including melanin synthesis). Specific subgroups, 
their specific names and their occurrence are mentioned where applicable. (Cortes et al. 
2005, Oetting et al. 2005, Rundshagen et al. 2002, Käsmann-Kellner et al. 2007, Hedge et 
al. 2002, Fitzpatrick et al. 1974).   
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1.2. Biochemistry 
 
As the genetic considerations have indicated already, albinism is related to the synthesis 
and transport of the pigment melanin. Here, melanin is a general name for a group of 
intensively coloured, mostly reddish, brown or black pigments synthesized in the human 
body primarily from the amino acid tyrosine. There are various polymeric structures 
subsumed under the umbrella of “melanin”, most of which are based on oxidized and 
subsequently polymerized hydroxyl-tyrosine moieties (Mason 1948, Lerner et al. 1950). 
The melanins vary as far as their chemical composition, appearance (colour) and 
biosynthetic pathways are concerned. Figure 2 briefly summarizes the two most important 
biosynthetic pathways of melanin in the human body, ultimately resulting in the “tyrosine 
only” polymer called eumelanin and the “tyrosine / cysteine” polymer pheomelanin (Ito and 
Wakamatsu 2011). Whilst both types of melanin differ considerably in their chemical 
structures and absorption spectra (i.e. colour), they share certain similarities when it 
comes to their biochemical pathways, which will now be considered in more detail. It 
should be mentioned from the outset that this overview is necessarily brief and focussed 
and hence cannot provide a complete overview of the rather complex (bio-) chemistry of 
the various forms of melanin. Recent reviews in this field may be consulted for more detail 
(Simon et al. 2009, Hearing 2011, Ito and Wakamatsu 2011).  
 
Despite the chemical diversity of the various melanins, the initial step in the melanin 
biosynthesis generally involves the hydroxylation and subsequent oxidation of the amino 
acid L-tyrosine to L-Dopaquinone (DQ) by the enzyme tyrosinase (E.C. 1.14.18.1) in the 
presence of molecular oxygen. As we will see later on, this enzyme forms the key to 
understating the various forms of OCA. L-Dopaquinone is the last metabolite shared by 
the eumelanin and pheomelanin synthetic pathways. Chemically speaking, this quinone is 
highly reactive and can undergo two distinct electrophilic reactions, either intramolecularly 
or with cysteine. In the first case, the nucleophilic amino group of L-Dopaquinone reacts 
intramolecularly with the quinone to form a cyclic molecule called cyclodopa. The latter 
can oxidize, on occasion decarboxylate and eventually polymerize in the presence of 
dioxygen and/ or certain enzymes (such as tyrosine related protein-1 Tyrp-1) to form 
various forms of eumelanin. 
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Figure 1.2: Biosynthetic pathways leading from the amino acid tyrosine to the two major 
forms of melanin, namely eumelanin (which is derived solely on tyrosine) and 
pheomelanin (which is derived from tyrosine and cysteine). CD = cysteinyl-dopaquinone, 
DQ = Dopaquinone. 
 
In the second case, the nucleophilic thiol group of cysteine reacts with the quinone to form 
2-S- or 5-S-cysteinyldopa in a ratio of 5:1. This adduct of two L-amino acids is 
subsequently oxidized to cysteinyl-dopaquinone (CD). CD is prone to a second 
nucleophilic attack at its quinone moiety, this time by the nucleophilic amine group of the 
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cysteine. This intramolecular reaction resembles the one in the eumelanin pathway (here 
involving the amine group of cysteine, there the amine group of tyrosine) and results in 
cyclic 1,4-benzothiazine intermediates which ultimately polymerize to form various types 
of pheomelanin. 
 
The overarching importance of the enzyme tyrosinase in both pathways is apparent and 
its pivotal role in the occurrence of albinism has already been illustrated in Table 1. 
Interestingly, the conversion of tyrosine to L-DOPA is also a key step in the biosynthesis of 
the neurotransmitter dopamine, yet the biosynthetic pathways leading to the melanins on 
the one hand and the neurotransmitters on the other (dopamine, norepinephrine, 
epinephrine etc.) differ. Whilst tyrosinase is a copper-containing enzyme with the E.C. 
number 1.14.18.1 (see above), the tyrosine hydroxylase responsible for the hydroxylation 
of L-tyrosine to L-DOPA is a rather different iron-containing hydroxylase with the E.C. 
number 1.14.16.12, which does not subsequently oxidize the hydroquinone to the (highly 
reactive) quinone required for nucleophilic attacks and / or polymerization. Furthermore, 
tyrosinase and tyrosine hyhydroxylase are found in different types of (human) cells. Here, 
tyrosinase is primarily but not exclusively present in the melanosomes of pigmented cells 
(melanocytes). Interestingly, this enzyme has also been isolated from lower animals, 
plants and even fungi, including mushrooms (Bourquelot and Bertrand 1895). 
 
Before finally turning our attention to the phenotypical and subsequently also more clinical 
aspects of albinism, we will briefly consider the (historical) background linking albinism to 
various mutations related to the tyrosinase system in general and tyrosinase in particular 
(in part reviewed by Hearing 2011). In 1908 A.E. Garrod was the first researcher who 
suggested that albinism was caused by an inborn error of metabolism (Garrod 1908). This 
is rather remarkable as enzymology at this time was still in its early infancy and the 
genetic issues surrounding albinism had also only just become apparent. A.E. Garrod 
mentioned tyrosinase in his publication, and hypothesized that it was the action of 
tyrosinase on tyrosine, possibly from protein hydrosylates, that was responsible for 
melanin formation. Indeed, the activity of the enzyme tyrosinase in various - lower - 
organisms was already known at this time (see above). At this point, A.E. Garrod did not, 
however, show a clear connection between lack of tyrosinase activity on the one hand and 
albinism on the other. 
 
Shortly after, the DOPA reaction of B. Bloch was used and it was shown that whilst albino 
hair follicles in both human skin and mouse contained melanocytes, they apparently 
lacked tyrosinase activity (Bloch 1917). At this point, the connection between albinism and 
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tyrosinase became firmly established and the “hair bulb test” was introduced which 
measures the ability of the hairbulb to turn brown when placed into a DOPA solution (such 
a hairbulb obviously contains active tyrosinase) (Oetting et al. 2003, Witcop et al. 1970). 
According to the “hair bulb test”, different forms of albinism were therefore classified as 
“tyrosinase positive” or “tyrosinase negative”. “Tyrosinase negative “indicated lack of any 
tyrosinase activity (Kugelman et al. 1961). Unfortunately, this test was neither particularly 
sensitive nor specific as it could not differentiate between the genetically different forms of 
albinism. Furthermore, this test obviously also depended on the amount of this enzyme 
present in the hair follicle, which changes during adolescence. Not surprisingly, the Bloch 
test sometimes produced a negative result in a young child, but became positive with age. 
Whilst this test can be seen as an early biochemical assessment recruited for medical 
diagnosis, it has been superseded by modern biochemistry and especially genetics and is 
no longer used. 
 
After the groundbreaking studies by enzymologists such as A.E. Garrod, the melanin 
biosynthesis pathway was elucidated in the 1920s by H.S. Raper and further details of this 
rather complex biosynthetic set of successive transformations were discovered by H.S. 
Mason, A.B. Lerner and T.B. Fitzpatrick in the 1940s and 1950s (Raper 1926, Mason 
1948, Fitzpatrick 1958). The biosynthetic pathway leading to melanins is therefore also 
commonly known as the Raper-Mason pathway, which has been refined further in the 
1960s and 1970s by the groups of A.B. Lerner at Yale and T.B. Fitzpatrick at Harvard 
(Hearing 2011). At this point, albinism was generally considered as a single gene disorder 
closely related to (mutations of) the enzyme tyrosinase. 
 
Two individual families of albinists reported by P.D. Trevor-Roper and C.J. Witkop, 
however, apparently disagreed with this theory (Trevor-Roper 1952). In each of these 
families, both parents, i.e. mother and father, were albinistic, yet the offspring was 
normally pigmented. Logically, as albinism is considered a recessive trait, a single - i.e. in 
both parents identical - mutation in the tyrosine gene would have to be present on both 
respective chromosomes of both parents, and hence the offspring should also inherit the 
mutation on both of its parental chromosomes, and therefore also be albinistic. As this 
was clearly not the case, the most logical explanation was that there could be several 
relevant mutations leading to albinism. Hence whilst one parent exhibited one particular 
mutation A on both chromosomes leading to albinism, the other parent had a different 
mutation B, also on both of her/his chromosomes and also leading to albinism. In sharp 
contrast, the non-albinistic children had inherited sets of chromosomes which had 
mutation A on one chromosome and mutation B on another, yet both mutations were 
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counterbalanced by non-mutated versions on “healthy” chromosomes. As albinism is a 
recessive trait, this constellation is obviously insufficient to result in an albinistic phenotype 
in the children. Interestingly, the presence (and absence) of albinism in these families is a 
clear indication that more than one mutation exists which ultimately may result in albinism. 
This rather instructive finding has been confirmed subsequently by genetic analysis, as 
discussed already in 1.1. 
 
Today, we know that albinism is not due to a single genetic / biochemical event but that 
different types of albinism exist which feature mutations in different genes and hence 
disrupt the biosynthesis of melanin at different points of the biosynthetic pathway - and 
with different severity. Whilst tyrosinase is clearly a key player in this pathway, and certain 
mutations in this enzyme may result in albinism, other mutations affecting other proteins 
are equally important (see Table 1.1). 
 
 
1.3. Albinism as lack of pigment in skin and hair 
 
Regardless of the precise genetic and subsequently biochemical cause or causes of albi-
nism, the resulting phenotype is well known and also implies some specific medical “con-
ditions”. In human skin, melanin primarily serves as a natural “sunscreen” due to its ability 
to absorb sunlight. Without the presence of melanin, the skin is suffering from hypopig-
mentation, i.e. a pale often slightly spotted skin. The fact that the skin is not completely 
free of any pigmentation is due to the circumstance that melanin is not the only pigment 
found in skin. Therefore persons with albinism may still have some colourful (often brown-
ish) spots in their skin due to other pigments. Furthermore, different forms of albinism dif-
fer in the severity of hypopigmentation, and some forms of albinism may not lead to a 
complete absence of any taint. 
 
Hypopigmentation by itself is not dangerous, yet the absence of the natural sunscreen in 
the skin implies, of course, that energy-rich fractions of sunlight, such as ultraviolet A light 
(wavelength 315 - 380 nm) may enter the skin cells unfiltered and may cause severe 
damage to the cell, especially to proteins and DNA. Such damage is often caused by the 
interaction of UV radiation with chromophobic small molecules or proteins in the skin, 
some of which are acting as photosensitizers and trigger the generation of highly reactive 
oxygen species (ROS) in the cells exposed to UVA. Ultimately, exposure to UVA and 
associated ROS generation may result in DNA modifications and, in the worst case, in 
skin cancer. In fact, the risk of developing skin cancer is 30 to 40 fold higher in lighter skin 
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when compared to darker skin (Hearing 2011). Additional benefits of pigmentation include 
cosmetic appearance (see below), detoxification (of radicals) and photo-protection in 
humans, and even camouflage and thermal regulation in amphibians. Whilst 
hypopigmentation is less of a health issue in regions where the exposure to sunlight is 
limited (such as in Northern Europe, Siberia, Canada, Alaska), it poses a significant health 
risk in Africa and equatorial regions of Asia and America. 
 
At the same time, albinism in African and Asian persons is also more obvious: despite 
being of a non-Caucasian origin, such albinistic persons appear as “white”. In Africa, 
people with albinism therefore not only possess a considerably higher risk of skin cancer 
but unfortunately, their appearance is also very different from the rest of the population 
and such persons are often socially stigmatized (see for instance BBC News, 27th of July 
2008). Here, some of the most bizarre stories have recently emerged from central Africa, 
including the belief that persons with albinism - and their body parts - possess healing 
properties. Sadly, this superstition has resulted in several killings and incidences of rape 
and possibly even cannibalism in countries such as Tanzania, Burundi and Zimbabwe. In 
contrast, lack of melanin in the skin is less apparent in Caucasian people, who have a 
fairly white skin, anyway, and there are no major reports of social stigmatization of 
albinists in present-day predominantly “white” societies. 
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2. Albinism from the ophthalmological perspective 
 
2.1. Albinism, syndromes and visual impairment 
 
Besides the various medical and in some instances social issues related to “fair” skin (and 
hair), the most significant impact of a disturbed melanin synthesis is probably not related 
to the skin or hair, but to the eye, and hence falls within the remit of ophthalmology. 
Depending on the degree by which the eye and / or skin (hair) is affected, one may 
distinguish between OCA and OA as the two major forms of albinism. OA is the typical 
ocular albinism which primarily affects the eyes whilst OCA is a form of albinism which 
affects the eyes, skin and hair (see also section 1). 
 
Notably, the effects of albinism on the eye are not just related to a “red pupil”, but also 
include a decreased differentiation of the central neurosensory retina and an atypical 
chiasmal crossing (i.e. the prevalence of crossed fibres). This is in part due to a 
hypopigmentation of the eye but also to a lack of melanin in the brain. Indeed, the 
occurrence of melanocytes is not limited to skin, hair and the eyes but also extends to the 
inner ear, the substantia nigra, the heart and even to adipose tissue (Zecca et al. 2001, 
Brito and Kos 2008, Zecca et al. 2008, Randhawa et al. 2009). Not surprisingly, there are 
various structural and functional pathologies associated with hypopigmentation in the eye 
and in the brain. Ultimately, the reduction of melanin in the eyes is characterized by 
several ocular abnormalities including foveal hypoplasia and the resulting decrease of 
visual acuity, misrouting of optic nerve fibres from the retina to the visual cortex, 
nystagmus, strabismus and translucency of the iris (Käsmann-Kellner et al. 2007). 
 
Various disorders and clinical syndromes are relevant to ophthalmology and have been 
associated with albinism in the past (see also section 1 and Table 1 in particular). Yet most 
of these disorders are not limited solely to an ophthalmological issue. Such syndromes 
include Hermansky-Pudlak syndrome (HPS), an autosomal recessive lysosomal storage 
disease of the reticuloendothelial system whose genetic location is on various 
Chromosomes (see Table 1). HPS occurs in various forms (Type 1 to 8) which are 
genetically very heterogeneous. In any case, HPS is characterized by OCA, platelet 
disorder (which leads to bleeding problems and lung fibrosis), granulomatous colitis and 
renal failure (Hermansky et al. 1959). 
 
Chediak–Higashi Syndrome (CHS) is an autosomal recessive disorder. Its genetic 
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location is chromosome 1q42.1-q42.2. CHS is characterized by OCA and 
immunodeficiency due to an associated white blood cell disorder (the leucocytes contain 
gigantic peroxidase granules). Most of the patients with CHS also develop a lympho-
proliferative syndrome with fever, jaundice, hepatosplenomegaly, pancytopenia and 
bleedings. Patients with CHS frequently require bone marrow transplantation, and without 
transplantation, life expectancy is only about ten years (Saez-De-Ocariz et al. 2008). 
 
Prader-Willi Syndrome (PWS) can be associated with OCA2. Its genetic location is the 
P-gene on Chromosome 15. 75% of patients suffering from PWS have a small deletion on 
the proximal part of the long arm of the paternally acquired chromosome 15 (15q11-q13). 
Most of the remaining 25 % of PWS sufferers exhibit two apparently normal, but 
maternally acquired chromosomes 15 (uniparental disomy). The prevalence of PWS is 
between 1 in 25,000 and 1 in 10,000 of live births. At birth, PWS is characterized by 
hypotonia, failure to thrive, lethargy and feeding difficulties. Later on in life, besides OCA2 
a range of additional health impediments may emerge, including hyperphagia, obesity, 
hypogonadism, hyperglycaemia, short stature, strabismus and intellectual delay (Cassidy 
1997). 
 
Angelman Syndrome (AS) may also be associated with OCA2. This syndrome was first 
described in 1965 by the British paediatrician, Dr. Harry Angelman (Angelman, 1965). AS 
is also a genetic disorder, with a mutation on the P-gene on Chromosome 15 (15q11-q13), 
similar to PWS (AS and PWS are sister syndromes). AS is characterized by intellectual 
and developmental delay, cognitive impairment, hyperactivity, frequent laughter and 
seizures (Angelman, 1965). 
 
Griscelli Syndrome (GS) has an autosomal recessive pattern of inheritance and is 
associated with OCA2. As in the case of the PWS and AS, the genetic location 
responsible for GS is Chromosome 15. GS can be subdivided into three types (Type 1 to 
3) and besides OCA2 is characterized by immunodeficiency, which often causes death in 
early childhood (Saez-De-Ocariz et al 2008). 
 
Waardenburg Syndrome (WS) is a genetic condition inherited in an autosomal dominant 
pattern. WS appears in four types (Type 1 to 4, with Type 3 and 4 being very rare) 
depending on the genetic location of the mutation responsible. WS is characterized by 
hypopigmentation of the iris, hair and skin as well as a sensorineural hearing loss 
(Waardenburg 1951). The Albinism deafness syndrome is thought to be a form of WS 
Type 2. It is characterized by congenital neural deafness and a piebald-like phenotype. 
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Piebaldism itself is an autosomal dominant condition and, unlike albinism, does not affect 
the eyes (normal pigmentation). Piebaldism is rather characterized by white forelocks, 
normally pigmented and hypopigmented skin patches and triangular hypopigmented areas 
on the forehead. 
 
While these syndromes in one aspect or another have been associated with albinism 
(mostly OCA2), the changes to the visual system in albinism are extensive and often also 
diverse. In order to understand better the impact albinism has on the eyesight of albinism 
patients in particular - and their quality of life in general - it is therefore necessary to 
literally keep a closer eye on the various changes to the visual system in albinism, which 
may occur besides the more obvious syndromes and OCA2. 
 
2.2. Phenotypes of the visual system in ocular and oculocutaneous albinism 
 
First of all, one should note that hypopigmentation has different effects on the morphology 
and function of the eye and the brain and, as a result, patients with albinism are not all 
“the same” but may exhibit a quite variable phenotype. This requires a more differentiated 
approach and a detailed classification of the stages and the levels of the ocular pathology. 
This classification assists with the individual assessment of each albinism patient and 
enables the ophthalmologist to assess if any (abnormal) changes are present. This 
classification is particularly important in the case of children, as it allows an early 
diagnosis and may also benefit support, such as Early Intervention which is the topic of 
this thesis. 
 
In albinism, we may generally distinguish structural and functional pathologies related to: 
■ Iris 
■ Retinal pigmentepithelium and macular differentiation 
■ Nervus Opticus 
■ Visual acuity 
■ Chiasmal crossings 
■ Binocular vision / squint 
■ Angle kappa κ 
■ Fixation / nystagmus 
■ Refraction 
■ Cerebral maturation / myelinisation / delayed visual maturation 
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In the following sections, we will consider briefly the typical features observed in the eye of 
persons with albinism. It should be mentioned from the outset that only a selection of the 
most significant pathological and non-pathological hallmarks of albinism in the eye can be 
covered, some of which are also relevant to this work. More comprehensive discussions 
related to the various morphological changes in albinism can be found in the recent 
literature (Cortes et al. 2005, Käsmann-Kellner et al.2003, Käsmann-Kellner et al 2007).  
 
2.2.1. Iris 
 
In persons affected by albinism, the colour of the iris itself is not affected directly, and, 
similar to non-albinistic persons, albinists may have blue, blue-grey or dark brown eyes, 
yet with variable degrees of iris translucency. The translucency of the iris is due to the lack 
of melanin in the iris pigment epithelium. In persons with albinism, the colour of the iris 
therefore often appears as “lighter” when compared to the one found in their next of kin. 
Yet this apparent change is not related to a particular type of OCA, it must rather be seen 
before an ethnical background. In Caucasians affected by OCA2, for instance, the colour 
of the iris is blue. In the same group of African patients, the iris appears as green-brown. 
 
Nonetheless, whilst hypopigmentation of the iris is not connected directly to OCA, it is also 
not just a “cosmetic” issue either, as the pigments also serve as natural filters for (energy 
rich, potentially damaging) light. Comparable to the situation in the skin, iris translucency 
results to an increased sensitivity towards light, and in the case of the eye, leads to 
photophobia. In the iris, there are four different degrees of hypopigmentation which are 
briefly summarized in Table 2.1. In this case, more severe degrees of hypopigmentation 
go hand in hand with a more severe sensitivity to light. 
 
Degree of 
Hypopigmentation 
Hallmark 
Degree 1 Translucency in a form of dots in the periphery of the iris 
Degree 2 Diffuse translucency in the periphery of the iris, pupillary margin well 
pigmented, not translucent 
Degree 3 Confluent translucency in the periphery of the iris, the margin of the lens 
is well distinguished in the periphery of the iris in a circular pattern, the 
pupillary margin is not translucent 
Degree 4 Complete translucency of the iris, the pupillary margin is translucent 
 
Table 2.1: Classification of the four degrees of hypopigmentation of the iris (Käsmann-
Kellner et al. 2007).  
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2.2.2. Retinal pigment epithelium (RPE) and differentiation of the macula 
 
The hypopigmentation of the RPE exhibits a variable degree of hypopigmented retinal 
periphery and lack of foveal landmarks. The topographic differentiation of central 
photoreceptors depends on the synthesis of pigment. Hypopigmentation results in variable 
degrees of foveal dysplasia and has an influence on the visual acuity later in life. There is 
a correlation between the mutation in the tyrosinase gene (OCA1, see section 1) and a 
30% reduction of ganglion cells. Optical coherence tomography (OCT) is able to detect a 
variety of foveal developmental abnormalities in albinism, from complete absence of 
foveal development to a central depression corresponding to a rudimentary annular reflex 
detected by ophthalmoscopy. Within this context, the often limited detection of foveal 
development (and abnormalities) in OCT as compared to other ophthalmoscopic 
techniques is likely due to poor fixation in patients with nystagmus (Harvey et al. 2006). 
 
Accordingly, the classification of hypopigmentation of the RPE results in four stages, each 
associated with a more pronounced degree of macular hypoplasy (Table 2.2). 
 
Degree of 
Hypopigmentation 
Hallmark 
Degree 1 Peripheral hypopigmentation of the RPE, foveal landmarks well 
structured  
Degree 2 Peripheral and central hypopigmentation of the RPE, Wall-reflex positive, 
foveal landmarks hypoplastic 
Degree 3 Significant peripheral and central hypopigmentation of the RPE, 
hypoplastic / dysplastic fovea and macula 
Degree 4 Stage 3 plus atypical retinal vessels, failing to wreath the fovea 
 
Table 2.2: Classification of the four degrees of hypopigmentation of the RPE and macular 
hypoplasy (Käsmann-Kellner et al 2007). 
 
2.2.3. Degrees optic nerve head (ONH) pathology 
 
In most patients with albinism, the optic nerve head is smaller than in persons not affected 
by albinism, and quite often also shows a hypo- or dysplasia. A dysplastic optic nerve 
head is more common in OCA1 patients (Käsmann-Kellner et al. 2007). 
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Such abnormalities related to the optical nerve seriously affect the eyesight of the person 
affected. Within this context, clinical data of over 500 patients examined in the Department 
of Ophthalmology of the University Hospital of Saarland (UKS) show a significant 
correlation between the degree of optic nerve head dysplasia on the one hand and visual 
acuity on the other (Käsmann-Kellner et al. 2007). Whilst there is also an apparent 
correlation between the type of albinism and the dysplasia of the optic nerve head, a 
correlation between the type of albinism or the stage of hypopigmentation of the iris or the 
retinal pigmentepithelium on the one hand, and visual acuity on the other, could not be 
observed in this study. These findings are rather surprising since optic nerve head 
dysplasia is particularly significant in the OCA1 type albinism, where it is present in 54% 
of OCA 1 patients, compared to a presence in only 14% of OCA2 and OA patients. Why 
such a strong prevalence of nerve head dysplasia in OCA1 patients does not firmly link 
OCA1 patients to a particularly poor visual acuity remains to be clarified. These results 
may require a thorough re-evaluation of the mechanisms underlying low visual acuity in 
albinism, that up to now were thought to be associated in one way or another with the 
ocular lack of pigmentation. 
 
Nonetheless, the staging of optic nerve pathology is still a valuable tool which assists in 
the determination of the correct diagnosis and prognosis of albinism affecting eyesight, 
especially in children. The correlation between the four degrees of the optical nerve head 
pathology on the one side and visual acuity on the other (Table 2.3) forms part of this 
thesis and will be discussed in more detail in the Results and Discussion section. 
 
Degree of 
ONH 
pathology 
Hallmark 
Degree 0 Normal ONH 
Degree 1 ONH pale but of normal size 
Degree 2 ONH small but vital 
Degree 3 ONH pale and small 
Degree 4 ONH dysplasia 
 
Table 2.3: Classification of the four degrees of ONH pathology. The latter can be used as 
part of the diagnosis and prognosis of the future impact of albinism on visual acuity, 
especially in children (Käsmann-Kellner et al. 2007). 
 
Whilst there is no direct correlation between the type of albinism or the stage of 
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hypopigmentation and visual acuity, the latter is often seriously affected by all forms of 
albinism. In many instances, a rather poor visual acuity across all types of albinism results 
in serious visual handicaps which will be reviewed in the next section. 
 
 
2.3. Visual acuity and the level of visual handicap 
 
As already mentioned, albinism in general affects the eyesight in different ways and in 
varying degrees of severity. This section will briefly consider the most apparent issues, 
problems and ultimately also pathologies associated with individual forms of albinism. 
Here, only a selection of the most apparent problems can be discussed, such as loss of 
visual acuity (which is the focus of this thesis), strabismus and nystagmus. Some of these 
deviations from normal eye morphology and eyesight result in distinct ophthalmic 
syndromes which will be mentioned and discussed briefly. 
 
It should be noted that the data presented in this section has been obtained as part of a 
larger study involving over 500 patients with albinism at the Department of Ophthalmology 
of the University Hospital of Saarland (UKS) (Käsmann-Kellner et al. 2007). These values 
are therefore representative of persons living in (this part of) Germany, and hence are 
directly relevant to the research conducted as part of this thesis. One must bear in mind, 
however, that this data and the various correlations discussed here - do not necessarily 
apply in the same manner or intensity to other populations (with different habits) or to 
different ethnical groups or to predominantly non-Caucasian populations. 
 
2.3.1. Visual acuity 
 
The visual acuity in persons affected by albinism varies widely, ranging from 0.01 to 1.2 
(compared to 1.0 in the case of normal visual acuity). As we will see in section 5, this wide 
spread of visual acuity results in considerable statistical variations and uncertainties. 
Hence, while the median visual acuity in patients suffering from various types of albinism 
is just 0.15 (Summers 1996, Käsmann-Kellner et al. 2007), there is a considerable spread 
and variability among albinists. Nonetheless, as this median value is rather low, many 
persons require medical assistance. The latter may include ophthalmological and 
refractive care and Early Intervention (see section 2.7), as well as low vision aid 
prescription, school, academic and professional rehabilitation services. Table 2.4 
summarizes the most common types of OCA and their typical hallmarks, in the context of 
skin, hair, visual acuity and the incidence of nystagmus. 
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Type Skin Hair VA Median 
VA 
Nystagmus 
(%) 
OCA 1A  No tanning Stays white 0.1 - 0.3 0.10 100 
OCA 1B Light tanning Turns darker later on in 
life, blond to brown, eye 
lashes darker than hair 
0.1 - 0.9 0.28 87 
OCA 2 Light tanning Turns darker later on in 
life, middle blond, eye 
lashes the same colour 
as hair 
0.1 - 0.8 0.24 95 
OCA 3 Pigmented Ginger 0.1 - 0.3 0.2 90 
OCA 4 Fair, no 
tanning 
White to brown 0.1 - 0.5 0.1 100 
OA Normal or a 
little fair 
All colours possible 0.1 - 0.8 0.12 92 
 
Table 2.4: Summary of the various types of OCA (Types 1, 2, 3 and 4), including the 
dermatologic phenotypes and median visual acuity associated with these specific types of 
OCA. Features of persons with OA are provided for comparison. VA = visual acuity. 
 
 
2.3.2. Atypical chiasmal crossings 
 
Patients with albinism are characterized by atypical chiasmal crossings. While there are 
only 30 to 50% crossed chiasmal fibres normally, in patients with albinism this percentage 
increases to 70 to 80% (yet rarely reaches 100%). Such atypical chiasmal crossings result 
in a characteristic picture in the Visually Evoked Potentials (VEP) examination. The 
visually evoked potential is an electric signal generated by the occipital visual cortex in 
response to stimulation of the retina by light (Kanski, 2008). The VEP examination is used 
to diagnose optic nerve diseases, particularly disorders which are the result of 
demyelination. In the case of albinism, a special recording technique of the VEP 
examination indeed can be rather useful in diagnosing patients with an otherwise less 
typical phenotype. Here, the extent of atypical chiasmal crossings correlates rather well 
with the type of albinism, and such crossings are more pronounced in patients with OCA1 
(Hoffmann et al.2003, Hoffmann et al. 2006, Käsmann-Kellner et al. 2007). 
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2.3.3. Strabismus 
 
Strabismus is extremely common in patients with albinism. It has been found in 83.6% of 
the 500 patients with albinism examined as part of the above-mentioned study at the UKS 
(Käsmann-Kellner et al. 2007). The prevalence of strabismus in patients with albinism 
depends on the type of albinism, and strabismus is most prevalent in patients with OCA1 
and OA (incidence rates in patients with OCA1: 93%, OCA2: 63%, OA: 93%, with a 
statistical significance of p < 0.005). In fact, the prevalence of strabismus is considerably 
higher in most patients with albinism compared to patients suffering from other congenital 
visual abnormalities, with the notable exception of patients with OCA2. Compared to other 
forms of OCA (and OA), OCA2 is associated with a markedly lower incidence of 
strabismus which is similar to the one found in patients with other congenital visual 
abnormalities, such as achromatopsia, aniridia or congenital cataract. 
 
Interestingly, the different forms of OCA also differ with respect to the prevalence of 
different sub-types of strabismus. The incidence of Strabismus divergens, for instance, is 
significantly higher in OCA compared to other underlying conditions of squint. 
Furthermore, the study conducted at the UKS has observed that albinism is sometimes 
observed in patients with Infantile Strabismus Syndrome. Here a VEP examination (see 
above) has been particularly useful as diagnostic tool. It has been able, for instance, to 
identify atypical chiasmal crossings in some children with otherwise full visual acuity yet 
suffering from Infantile Strabismus Syndrome (Käsmann-Kellner et al. 2007), thus 
broadening the etiological aspects of infantile strabismus. 
 
2.3.4. Positive Angle Kappa 
 
Whilst the pupillary axis is defined as a perpendicular line through the cornea and the 
centre of pupil, the visual axis connects the fixation object and the fovea. The angle 
between these two axes is called kappa (κ). In normal patients, this angle is slightly 
positive as in healthy eyes the fovea is positioned slightly temporally from the pupillary 
axis. In contrast, a negative value for κ suggests Strabismus convergens and an 
increased, i.e. exceptionally large value for κ implies Strabismus divergens. As far as 
patients with albinism are concerned, an increased, highly positive κ has been found in 
about 50% of these patients (Brodsky et al. 2004, Summers et al. 2004, Käsmann-Kellner 
et al. 2007). As a very positive angle kappa may simulate a divergent squint, examinations 
related to strabismus in persons with albinism need to include an observation of the 
corneal reflex in monofixation of both eyes. 
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2.3.5. Nystagmus 
 
Horizontal pendular and later jerk nystagmus is also linked to albinism where it generally 
occurs between the 8th and 12th week of life. The intensity of nystagmus (intensity = 
frequency x amplitude, given in Hz) changes significantly during the first four to six years 
of life and reaches a steady state between the sixth and eighth year. In the first years it is 
characterized by a change from pendular to jerk nystagmus and by a reduction of 
amplitude. Some patients with nystagmus adopt an abnormal head posture to take 
advantage of the so-called neutral zone, where nystagmus intensity is less (Käsmann 
2000, Käsmann-Kellner et al. 2007). It should be emphasized that today it is possible to 
reduce nystagmus surgically in certain clinical constellations at or after five years of age. 
 
2.3.6. Refraction 
 
Albinism is also associated with a high prevalence of abnormalities in refraction. About 
two thirds of patients with albinism suffer from hyperopic astigmatism and one third from 
myopic astigmatism. Such anomalies with respect to refraction are already present in 
babies. As far as astigmatism is concerned, the grade of the optic nerve head dysplasia 
(see section 2.2.3.) directly correlates with a very high astigmatic refraction. In this case, 
the prescription of glasses is indicated as early as possible. An appropriate correction of 
these anomalies has a positive effect on the visual development later on in life. As 
albinism is also associated with a particular sensitivity to light (see section 1), two pairs of 
glasses are usually recommended, one with a light absorption of 20% and the other with a 
light absorption of 80% (Summers 1996, Käsmann-Kellner et al. 2007).  
 
2.3.7. Delayed visual maturation (DVM) 
 
A delayed visual maturation (DVM) is found in 50 to 75% of children affected by albinism. 
Here, a diagnosis of DVM should not lead to the premature conclusion that the child is 
actually blind. Indeed, the extent of DVM differs considerably between patients with 
albinism and its grade correlates with the abnormalities associated with the optic nerve 
head (Käsmann-Kellner et al. 2007). DVM is characterized by a delay in the onset of 
fixation in newborn babies. Fixation normally starts between the 4th and 8th week of life, 
and is occasionally delayed until the 12th week. No fixation after the 12th week is 
considered as delayed visual maturation and requires further evaluation. In albinism, this 
process can be delayed up to the 10th month of life. 
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The children suffering from DVM show the following signs (Duckman 2008): 
 
■ No fixation by 2 to 4 months after birth 
■ No eye contact 
■ No explorative visual behaviour 
■ No significant pathology in visual pathways or brain 
 
There are four types of DVM, referred to as DVM 1 - DVM 4 (Duckman 2008). DVM 1 is 
characterized by: 
 
■ Neurological development and findings are normal 
■ No systemic abnormalities 
■ Electroretinogram (ERG) is often normal 
■ VEPs may be normal or abnormal, but present 
■ Electroencephalogram (EEG) is normal 
■ Normal ocular examination results 
■ Most patients show the signs by three months of age 
■ Resolution takes rarely longer than 6 to 7 months 
 
DVM 1 is further divided in two subgroups, namely DVM 1A and DVM 1B. DVM 1A is a 
form of DVM 1 with no perinatal complications, whilst DVN 1B is a form of DVM1 with 
perinatal complications. 
 
DVM 2 is characterized by DVM with systemic disease and/or neuro-developmental 
abnormalities. 
 
DVM 3 is DVM associated with nystagmus and oculo-cutaneous albinism. The loss of 
visual function is significantly higher than would be predicted on the basis of nystagmus or 
albinism alone. 
 
DVM 4 is DVM associated with congenital bilateral ocular abnormalities. The loss of visual 
function is significantly higher than would be predicted on the basis of the ocular 
abnormality alone. 
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After successful fixation the Sensitive Phase of visual maturation sets in, which itself 
consists of two phases. The Morphologically Plastic Phase usually lasts from the 8th to 
10th month of age while the Functionally Plastic Phase may last up to 7 to 10 years of age. 
During these phases, various corrections or treatments are possible, which interfere with, 
guide or correct the maturation process. Here, a classical example is the treatment of 
amblyopia. It is therefore advisable that patients with albinism should also be involved in 
adequate supportive actions, such as Early Intervention, as early in life as possible (see 
section 2.4 and section 3). 
 
 
2.4. Early Intervention (“Fruehfoerderung”) 
 
In the field of any paediatric subspecialty, Early Intervention is a general term which 
subsumes various supportive, non-invasive therapies for children aiming to improve the 
quality of life. These strategies are known as “Fruehfoerderung” in German, and appear in 
the Anglo-Saxon medical literature under various names, including ‘visual stimulation’, 
‘visual learning’, ‘early occupational therapy’, ‘exemplary early support’, ‘early education’, 
‘Early Intervention’ etc. Here, the term ‘Early Intervention’ (EI) will be used to represent 
these different strategies, as ‘Early Intervention’ seems to be the most adequate and also 
the most inclusive of these expressions. 
 
In the German-speaking medical community, Early Intervention for visually handicapped 
and blind children as a comprehensive strategy can be traced back to the 1980s, for 
instance to the introduction of such an approach at the Hospital “Barmherzige Brueder” 
(“Good Samaritans”) in Linz, Austria in 1986 (Priglinger et al. 1993). This does not, 
however, rule out that some related, yet probably less structured methods may have been 
used previously elsewhere, or that such strategies were implemented earlier on by other 
hospitals which failed to report them in the literature. 
 
Today, the key elements of Early Intervention are represented by the following training 
schemes (Zihl et al. 2012): 
 
■ Visual exploration 
■ Visual localisation and orientation in the room 
■ Visual differentiation of colours and forms 
■ Visual differentiation of objects and faces 
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■ Development of visual memory 
■ Visual differentiation of details and visual-cognitive discrimination of “Gestalt” and 
figure - ground - phenomenon 
 
The impact of Early Intervention on the visual function in children has been studied soon 
after the introduction of this method in the 1980s. In 1993, Priglinger et al. have reported a 
comprehensive, yet from a statistical point of view rather limited study with 49 children, 
where the authors have evaluated visual acuity of these children in response to Early 
Intervention. In 34 of these patients, an improved visual function has been observed in 
everyday life. Yet only 15 of the 49 children showed a measurable improvement of visual 
acuity, which also was rather small (0.1 to 0.2). Notably, these children belonged to a 
group of patients suffering from an atrophic optic nerve (Priglinger et al. 1993). 
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3. Hypothesis 
 
As mentioned in the Introduction, the genetic, biochemical and - above all - clinical 
evidence currently available points towards a significant correlation between albinism and 
a wide range of more or less severe ophthalmological disorders. In several cases, such as 
DVM, therapeutic interference with delayed or insufficient processes due to albinism 
seems to be possible, at least in theory. Not all of these interventions need to involve 
surgery or medication. As already indicated in the previous sections, a milder form of such 
an interference may involve Early Intervention (in children) in order to compensate for the 
delay in normal development.  
 
The main objective of the research presented here therefore has been to explore a 
possible link between Early Intervention on the one side and improved visual acuity in 
patients having undergone this treatment as compared to patients with no Early 
Intervention on the other. Here, visual acuity (VA), rather than any of the other visual 
handicaps discussed in section 2, has been selected as an indicator of an improved 
eyesight, as it affects most patients with different forms of OA and OCA rather severely 
(the median of visual acuity in various forms of albinism is just 0.15 compared to 1.0 in 
normal persons (Käsmann-Kellner et al. 2007). VA can also be measured rather readily, 
mostly precisely and reliably, and allows a proper, objective statistical evaluation of the 
data generated. Furthermore, data on visual acuity is readily available. 
 
The main hypothesis of this research is therefore that Early Intervention 
significantly improves visual acuity in children. 
 
This general hypothesis results in a set of more specific individual research questions 
which can be addressed by statistical evaluation. 
 
First and foremost, visual acuity critically depends on the morphology of the optic nerve 
head (Käsmann-Kellner et al. 2007). It is therefore of considerable interest to see if the 
optic nerve morphology is the same in test and control groups. If, for instance, the optic 
nerve morphology would be much better in the test group in comparison with the control 
group, it would not be possible to link any improvement of visual acuity to Early 
Intervention. 
 
After clarification of this issue, the possible link between Early Intervention and visual 
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acuity can be examined in more general terms, i.e. for a cohort of children aged 6 to 15, 
all of whom have received Early Intervention. The visual acuity of this cohort can then be 
compared to a control group consisting of (older) patients who have never received any 
Early Intervention treatment. 
 
Furthermore, as explained in the introduction, some of the ophthalmic disorders 
associated with albinism are gender specific. Hence a separate consideration of female 
and male patients is sensible to see if Early Intervention makes specific sense in female 
or male patients. 
 
Ultimately, the following specific assumptions or questions for investigation emerge and 
will be addressed as part of this thesis. 
 
■ Is there is a strong correlation between optical nerve head morphology and visual 
acuity in patients with albinism, and if yes, is it similar to the control group? 
 
■ Is Early Intervention effective in children whose visual maturation is still ongoing, i.e. is 
there a subsequent improvement of visual acuity in children with completed Early 
Intervention aged 6 to 15? 
 
■ Is it possible that the benefits of Early Intervention are gender specific? 
 
■ Does any improvement achieved by Early Intervention match or even outpace the 
impact of various morphological pathologies (iris, macula, optic nerve) on visual acuity? 
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4. Methods 
 
4.1. Samples and individual cohorts 
 
In order to investigate the various hypotheses put forward in section 3, it is necessary to 
collect data from a wide range of children with albinism. Here, substantial cohorts of 
probands are required to achieve statistical significance, which obviously have to exceed 
the size of previous studies, for instance the one by Priglinger et al.1993. Therefore, the 
relevant data has been collected for a total of 232 patients with albinism (children, aged 6 
to 15) from the Archive of the Department of Ophthalmology of the University Hospital of 
Saarland in Homburg/Saar. This cohort is considerably larger than the one studied in a 
similar context by Priglinger et al. in the early 1990s. In the study reported here, the test 
group consists of children, aged 6 to 15, who have received Early Intervention. Indeed, 
Early Intervention is carried out at the infantile age from age 0 to 6. In this study we are 
therefore focusing on the age group from 6 to 15, because these children have most 
recently undergone and also completed Early Intervention. The control group comprises a 
total of 139 of patients at the Department of Ophthalmology aged over 25 who have not 
received Early Intervention. The total sample size of the test and control group is therefore 
371. Table 4.1 summarizes the size of the individual cohorts. 
 
Cohort Female Male Total 
Test group 
(aged 6-15) 
With EI 
98 134 232 
Control group 
(aged 25+) 
No EI 
68 71 139 
Total 166 205 371 
 
Table 4.1: Overview of the different cohorts (and their respective sizes in number of 
patients) used in order to address the general hypothesis and the age- and gender-
specific aspects of this study. EI = early Intervention. 
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Table 4.1 summarizes the various cohorts used for this study. These cohorts were 
sufficient in size in order to derive at statistically useful results. A similar separation of the 
total of patients with and without Early Intervention has been undertaken to investigate the 
correlation between visual acuity and the morphological degree of Iris, Optic Nerve and 
Macula pathology.  
 
 
4.2. Initial assessment of the normal distribution of the data sets 
 
The statistical evaluation of the data has been performed with the Statistical Package for 
the Social Sciences (SPSS 17.0). In the first step the various data sets and suspected 
correlations have been analyzed to determine if the distributions at hand follow a normal 
distribution or not. Such an initial analysis of the data sets is required to determine which 
algorithm is used subsequently to calculate the correlations and statistical significances 
(see below). This initial assessment of the data collected has been performed in SPSS 
employing the Shapiro-Wilk test, which is based on a so-called Q-Q plot, comparing 
histograms and box-plots and calculating the two relevant parameters known as 
skewness and kurtosis. 
 
Here, the Shapiro–Wilk test is a test of normality used in statistics. It has been developed 
in 1965 by Samuel Sanford Shapiro and Martin Wilk. The null-hypothesis of this test is 
that the population is normally distributed. If the p-value is less than 0.05 (pSW < 0.05), the 
null hypothesis is rejected and the data tested are not from a normally distributed 
population. In other words, the data is not normal. If the p-value is greater than 0.05, then 
the null hypothesis is considered as “verified” and the data at hand can be analysed 
further using an algorithm applicable to normally distributed data sets. 
 
Whilst the pSW value provides a good indication to decide if a set of data is normally 
distributed or not, it is often not sufficient to arrive at a firm conclusion. Hence additional 
information is sought in form of a Q-Q plot, the skewness and kurtosis of the data and its 
distribution (Wilk et al. 1965). The Q-Q plot is a probability plot which allows the 
comparison of two probability distributions by plotting their quantiles against each other. It 
is a graphical method which compares the shapes of distributions in a more qualitative 
manner. It shows, for instance, if relevant properties of two given distributions, such as 
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location, scale, and skewness, are similar or different in the two distributions. A Q-Q plot is 
generally a better method to analyse statistical data than the common technique of 
comparing histograms of the two samples (Wilk et al 1968). It is often complemented by a 
more quantitative analysis of the “shape” of the distribution(s) at hand. Here, skewness 
and kurtosis are relevant parameters used in statistics to describe the shape of 
distributions. Skewness is a measure of the asymmetry of the distribution around its 
mean. The skewness value can be positive or negative, or undefined. Kurtosis is any 
measure of the "peakedness" of the probability distribution. It originates from the Greek 
word kurtos and means curved or arched. Together, skewness and kurtosis represent 
semi-quantitative descriptors of the shape of a probability distribution (Joanes et al 1998). 
 
As part of this study, pSW, skewness and kurtosis have been calculated first for each data 
set and correlation under investigation. Based on the outcome of this calculation, it has 
been decided to treat the data as either normally or non-normally distributed. Based on 
this decision, the correlation and its associated significance has then been calculated 
using either the Pearson product-moment correlation coefficient (PPMCC or PCC or 
Pearson's r) or the Spearman’s rank correlation coefficient. 
 
 
4.3. Analysis using Pearson product-moment or Spearman's rank correlation 
coefficient 
 
The Pearson product-moment correlation coefficient (PPMCC or PCC or Pearson's r) is 
used for normally distributed data (psw > 0.05, see above). It provides a measure of the 
linear correlation (dependence) between two variables X and Y. The value obtained re-
sides between +1 and −1 inclusive, where 1 is totally positive correlation, 0 is no correla-
tion, and −1 is totally negative correlation. This algorithm has been introduced by Karl 
Pearson in the 1880s (Fischer et al. 1915) and is used in Science as a measure of the 
degree of linear dependence between two variables. 
 
In contrast, the Spearman's rank correlation coefficient or Spearman's rho is applicable for 
data which is not normally distributed (psw < 0.05). Developed by Charles Spearman at the 
beginning of the 20th Century, this algorithm assesses how well the relationship between 
two variables can be described using a monotonic function. If there are no repeated data 
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values, a perfect Spearman correlation of +1 or −1 occurs when each of the variables is a 
perfect monotone function of the other. Spearman's coefficient is calculated for continuous 
and discrete variables, including ordinal variables (Fieller et al. 1957). 
 
As part of this thesis, both algorithms have been used as adequate for either normally or 
non-normally distributed data. It should be noted, however, that in some instances, very 
similar sets of data have demanded the use of either Pearson’s or Spearman’s analysis 
based on the outcome of the initial analysis described in 4.2. In such cases, a direct com-
parison of parameters from the Pearson analysis with the one from the Spearman analy-
sis may have become necessary. To avoid a direct - and certainly problematic - compari-
son of parameters obtained by different algorithms it has been decided in these cases to 
perform the calculation using both methods for better comparison. Yet the results obtained 
with the “correct” algorithm are clearly marked in order to avoid any misunderstandings. 
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5. Results 
 
Employing the various data sets and an appropriate statistical analysis as described in the 
Methods section, a number of key findings have been obtained which are presented 
below. 
 
In the first instance, the “anatomical” similarity of the two cohorts, i.e. the test group and 
the control group has been confirmed to ensure that both groups do not differ per se 
regarding their morphological degree of optical nerve pathology. This investigation 
ensures that there is no statistically significant difference in optic nerve pathology between 
the test group and the control group (Figure 5.1). It implies that both groups are 
statistically comparable for the optic nerve head anatomy. Therefore it is subsequently 
possible to consider the effect of Early Intervention as the primary, possibly even the sole 
underlying cause of any changes in visual acuity which may be observed. This wouldn’t 
be the case if optic nerve morphology were much better in - for instance - the test group. 
 
As described in the Methods section, the individual data sets have then been analysed 
with the Shapiro-Wilk test to determine if the data follows a normal distribution or not. 
Within this context, the data sets have been tested by visual inspection of the histograms, 
normal Q-Q plots and box-plots and a calculation of skewness and kurtosis. As it turns 
out, virtually all of the data sets forming part of this study are not normally distributed. 
Therefore Spearman’s rho correlation is appropriately used to evaluate any correlations 
and statistical significances which may exist within of these sets of data. Nonetheless, 
using this kind of pre-analysis “first inspection”, two exceptions have been observed which 
ask for an analysis using the Pearson correlation and significance. One exception is found 
in the correlation of visual acuity and morphological degrees 1 and 2 of iris pathology in 
the age group 25+. The other exception is noted in the the correlation of visual acuity and 
morphological degrees of optic nerve pathology (Degree 0, normal optic nerve) in the 
same age group. These data are normally distributed. 
 
In order to avoid any confusion, both the Pearson correlation and Spearman’s rho 
correlation are shown in the following when discussing data sets (see section 4.3.). Based 
on the Shapiro-Wilk test, however, the most appropriate form of analysis (either Pearson 
or Spearman’s rho) is shown in black whilst the less appropriate is shown in fading grey 
for comparison. The relevant information on the p-value of the Shapiro-Wilk analysis 
(pSW), skewness and kurtosis is then provided in the legend of each figure for information.  
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5.1. Morphology of the Optic Nerve Head (ONH) in control and test groups 
 
As already mentioned in section 2 it appears that the ONH pathology may be the most 
important factor in determining visual acuity. It was therefore tested whether the control 
and test groups are statistically comparable concerning this particular parameter. Such a 
similarity in ONH pathology is a prerequisite for any further analysis with regard to Early 
Intervention. 
 
Correlations 
  Morphological degrees of 
optic nerve pathology  Age 
Morphological degrees of 
optic nerve pathology  
Pearson Correlation 1 -,016 
Sig. (2-tailed)  ,762 
N 371 371 
Age Pearson Correlation -,016 1 
Sig. (2-tailed) ,762  
N 371 371 
 
 
 
   Morphological 
degrees of optic 
nerve pathology  Age 
Spearman's rho Morphological degrees of 
optic nerve pathology  
Correlation Coefficient 1,000 -,003 
Sig. (2-tailed) . ,948 
N 371 371 
Age Correlation Coefficient -,003 1,000 
Sig. (2-tailed) ,948 . 
N 371 371 
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Figure 5.1: Correlation of age and morphological stages of optic nerve pathology between 
the two selected age groups 6 - 15 and 25+, n = 371. The Spearman’s rho correlation 
coefficient is 0.003 and the (Spearman’s) significance is 0.948, i.e. considerably higher 
than 0.01. The correlation and significance values indicate that the correlation is not 
statistically significant. Age group 6-15 and age group 25+ pSW < 0.05. Age group 6-15 
skewness -2.93, kurtosis -3.56. Age group 25+ skewness –1.158, kurtosis -3.17. 
 
The data shown in Figure 5.1 indicates that the morphological stages of optic nerve 
pathology do not correlate with the age groups as the significance of 0.948 is considerably 
higher than 0.01. This implies that the optic nerve pathology is vastly independent of the 
age group, i.e. is “more or less the same” in both groups. Hence there are no statistically 
relevant differences in optic nerve pathology and any differences subsequently observed 
between the two cohorts must originate from another factor or factors. 
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5.2. Visual Acuity in control and test groups 
 
After ensuring that the two individual groups do not differ per se due to differences in the 
morphological degree of optic nerve pathology, and hence can be compared, the 
relationship between visual acuity and Early Intervention has been investigated. Here, 
Figure 5.2 at first “visual” inspection seems to indicate that the visual acuity (VA) in the 
test group (children aged 6 to 15) is slightly better in comparison with the control group 
(patients aged over 25). The median visual acuity in the test group is around 0.18 
whereas in the control group it is slightly lower, around 0.15. At the same time, the box 
plot for the test group, compared to the control group, indicates that the first quartile 
extends to slightly higher, i.e. better values for visual acuity. Yet whilst the box plot 
graphically seems to point towards an improved visual acuity in the test group, this 
improvement, however, is not statistically significant. The Spearman’s rho correlation 
coefficient is 0.003 and the significance is 0.949, i.e. considerably higher than 0.01, 
indicating that the correlation is not significant statistically. 
 
Correlations 
  Age Visual acuity 
Age Pearson Correlation 1 ,015 
Sig. (2-tailed)  ,770 
N 371 371 
Visual acuity Pearson Correlation ,015 1 
Sig. (2-tailed) ,770  
N 371 371 
 
Correlations 
   Age Visual acuity 
Spearman's rho Age Correlation Coefficient 1,000 ,003 
Sig. (2-tailed) . ,949 
N 371 371 
Visual acuity Correlation Coefficient ,003 1,000 
Sig. (2-tailed) ,949 . 
N 371 371 
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Figure 5.2: Correlation of age and visual acuity between the two selected age groups 6 - 
15 and 25+, males and females, n = 371. Age group 6-15 and age group 25+ pSW < 0.05. 
Age group 6-15 skewness 10.29, kurtosis 7.07. Age group 25+ skewness 7.95, kurtosis 
4.29. Whilst at first glance, there seems to be a slightly improved VA in the children 
compared to the control group, this difference is not relevant statistically. 
 
 
5.3. Gender specific improvement of visual acuity due to Early Intervention 
 
The lack of any general and statistically significant improvement in the children compared 
to the control group is disappointing as it seems to refute the hypothesis that Early 
Intervention has a pronounced effect on (most of) the children who have previously 
undergone this particular treatment. Nonetheless, such a more general finding across a 
rather large population of 232 children in the test group and 139 older persons in the 25+ 
control group may conceal significant improvements of visual acuity in individual patients 
or sub-groups of patients. As highlighted in section 1, there are significant gender specific 
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differences due to the particular inheritance of albinism, and therefore a gender specific 
analysis of visual acuity in the control and test groups has been performed. 
 
The results obtained for the female subgroups are shown in Figure 5.3. As in Figure 5.2, 
a generally higher visual acuity is noticed in the test group compared to the control group. 
At first inspection of the box plots, the median visual acuity is around 0.2 in the test group, 
whilst it is lower, around 0.15, in the control group. At the same time, the first quartile also 
extends to a higher, i.e. better acuity in the test group compared to the control group (0.4 
and 0.3, respectively). Nonetheless, the characteristic statistical parameters still point at a 
rather weak, non-significant correlation. The Spearman’s rho correlation coefficient is -
0.085 with a significance of 0.275, indicating that indeed there is a better visual acuity in 
the test group compared to the control group (negative correlation values), but also that 
the correlation is not significant. Nonetheless, a significance of 0.275 is considerably 
better than in Figure 5.2 (0.949), yet still well above 0.01 and hence not significant from a 
statistical point of view. 
 
Correlations 
  Age Visual acuity 
Age Pearson Correlation 1 -,092 
Sig. (2-tailed)  ,238 
N 166 166 
Visual acuity Pearson Correlation -,092 1 
Sig. (2-tailed) ,238  
N 166 166 
 
Correlations 
   Age Visual acuity 
Spearman's rho Age Correlation Coefficient 1,000 -,085 
Sig. (2-tailed) . ,275 
N 166 166 
Visual acuity Correlation Coefficient -,085 1,000 
Sig. (2-tailed) ,275 . 
N 166 166 
  
Early Intervention in Albinism 
44 
 
 
 
Figure 5.3: Correlation of age and visual acuity in females in the two selected age groups 
6 - 15 and 25+, n =166. Age group 6-15 and age group 25+ pSW < 0.05. Age group 6-15 
skewness 5.82, kurtosis 3.18. Age group 25+ skewness 7.24, kurtosis 7.14. 
 
Interestingly, whilst despite the lack of a statistical significance there seems to be a small 
but measurable improvement of visual acuity upon Early Intervention, this effect is notably 
absent in the group of males. As Figure 5.4 indicates the median visual acuity is almost 
the same in both groups, i.e. around 0.15 in the test as well as the control group. At the 
same time, the height of the box plots indicative of the first quartile are almost “mirrored” 
compared to the female population. It therefore seems that in the case of males, the 
control group has the better visual acuity compared to the test group. This first impression 
is supported by the relevant statistical parameters. The Spearman’s rho correlation 
coefficient is 0.067 and the significance is 0.342, pointing towards an even slightly worse 
(the correlation coefficient this time is positive), but again not statistically significant visual 
acuity in the test group. This finding will be discussed in more detail in the Discussion. 
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Correlations 
  Age Visual acuity 
Age Pearson Correlation 1 ,102 
Sig. (2-tailed)  ,146 
N 205 205 
Visual acuity Pearson Correlation ,102 1 
Sig. (2-tailed) ,146  
N 205 205 
 
 
Correlations 
   Age Visual acuity 
Spearman's rho Age Correlation Coefficient 1,000 ,067 
Sig. (2-tailed) . ,342 
N 205 205 
Visual acuity Correlation Coefficient ,067 1,000 
Sig. (2-tailed) ,342 . 
N 205 205 
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Figure 5.4: Correlation of age and visual acuity in males in the two selected age groups 6 
- 15 and 25+, n = 205. Age group 6-15 and age group 25+ pSW < 0.05. Age group 6-15 
skewness 8.8, kurtosis 7.29. Age group 25+ skewness 4.59, kurtosis 1.0. 
 
 
5.4. Does gender have a general influence on Visual Acuity? 
 
Importantly, an improved visual acuity in females could also be independent of Early 
Intervention, i.e. a more “natural effect” (e.g. genetically linked). The visual acuity of 
females and males has therefore been compared in both groups in order to establish - or 
rule out - any possible link between gender and a generally improved visual acuity. Figure 
5.5 illustrates the gender-specific distribution of visual acuity in the control group. If there 
would be a more general impact of gender on visual acuity, for instance because of X-
chromosome linked inheritance of certain mutations, then this general influence should be 
apparent in the control group of persons 25+ as well. 
 
In fact, the median visual acuity in the male population and female population of the 
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control group is around 0.2 and 0.15, respectively, actually pointing towards a generally 
better “natural” visual acuity in males (and not in females as may have been predicted). 
Furthermore, the first quartile of the box plot in the male population is somewhat higher 
than in female population (0.4 and 0.3, respectively). As expected from this visual 
inspection of the box plots, the analysis using Spearman’s rho correlation is negative at -
0.118, pointing towards a lower visual acuity in the female cohort, yet this is not 
statistically significant as the significance parameter calculated is 0.166, i.e. well above 
0.01. In any case, whilst this decrease in visual acuity in the female cohort compared to 
the male cohort is not statistically significant, it clearly refutes the initial suspicion raised in 
Figures 5.3 and 5.4 that females may “naturally” have a better visual acuity compared to 
males. 
 
Correlations 
 
  Visual acuity Sex 
Visual acuity Pearson Correlation 1 -,090 
Sig. (2-tailed)  ,290 
N 139 139 
Sex Pearson Correlation -,090 1 
Sig. (2-tailed) ,290  
N 139 139 
 
Correlations 
   Visual acuity Sex 
Spearman's rho Visual acuity Correlation Coefficient 1,000 -,118 
Sig. (2-tailed) . ,166 
N 139 139 
Sex Correlation Coefficient -,118 1,000 
Sig. (2-tailed) ,166 . 
N 139 139 
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Figure 5.5: Box plot and nonparametric correlation of visual acuity and gender of the 
control group, age group 25 +, n = 139. Age group 25+ pSW < 0.05. Male group skewness 
4.27, kurtosis 0.69.Female group skewness 6.6, kurtosis 5.11.  
Whilst the data obtained for the control group age 25+ clearly contradicts the idea that 
gender matters in general terms, gender indeed seems to be responsible for a 
considerable difference in visual acuity once the children who have undergone Early 
Intervention are considered. As shown in Figure 5.6, the median visual acuity in females 
of this group is considerably higher than in males, at around 0.5 compared to 0.2. In line 
with this visual inspection of the box plot, the Spearman’s rho correlation coefficient is 
rather positive, at 0.058, with a significance of 0.378. 
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Correlations 
  Visual acuity Sex 
Visual acuity Pearson Correlation 1 ,036 
Sig. (2-tailed)  ,590 
N 232 232 
Sex Pearson Correlation ,036 1 
Sig. (2-tailed) ,590  
N 232 232 
 
 
Correlations 
   Visual acuity Sex 
Spearman's rho Visual acuity Correlation Coefficient 1,000 ,058 
Sig. (2-tailed) . ,378 
N 232 232 
Sex Correlation Coefficient ,058 1,000 
Sig. (2-tailed) ,378 . 
N 232 232 
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Figure 5.6: Box plot and nonparametric correlation of visual acuity and sex of the test 
group, age group 6-15, n = 232. Age group 6-15 p<0.05. Male group skewness 9.11, 
kurtosis 7.54.Female group skewness 5.87, kurtosis 3.76.  
Whilst the significances in Figures 5.5 and 5.6 still are not sufficient to postulate a firm 
correlation, they nonetheless confirm that (a) the apparent improvement of visual acuity in 
females is not due to a generally improved visual acuity in women and that (b) there is a 
clear, albeit not statistically significant improved visual acuity of females with Early 
Intervention not only compared to the females in the control group but also compared to 
the males in the test group itself. These findings are of considerable interest as they point 
towards a better impact of Early Intervention in young girls. They will be discussed in more 
detail in section 6. 
 
Despite these rather revealing findings, it seems that Early Intervention can only exert a 
small - and strictly speaking non-significant - effect on visual acuity. The anticipated 
improvements are too small to be significant, and this in turn raises the question if there 
are any other factors which may determine visual acuity and hence impact on the 
outcome of Early Intervention. Here, “anatomical” aspects of the eye first come to mind 
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(see also section 2). These factors include, for instance, iris morphology, macular 
pathomorphology, optic nerve head pathology and strabismus, which have also been 
analysed as part of this study. 
 
 
5.5. Visual Acuity and morphological parameters in test and control group 
 
5.5.1. Visual Acuity and Iris Pathology 
 
Indeed, as Figure 5.7 indicates, there is a statistically highly significant correlation 
between visual acuity and the morphological degrees of iris pathology in the test group. 
The Spearman’s rho correlation coefficient is -0.193, pointing towards a lower visual acuity 
with higher degrees of iris pathology, and in this case the significance is extraordinarily 
high, at 0.002. When comparing these results for iris pathology with the ones for Early 
Intervention, it is apparent that the pathology clearly outpaces any small effects due to 
Early Intervention, in both respects, the extent of differences in visual acuity (0.2 units) as 
well as its significance. 
 
Correlations 
  Morphological stages of 
iris pathology Visual acuity 
Morphological  degreesof iris 
pathology 
Pearson Correlation 1 -,175
**
 
Sig. (1-tailed)  ,004 
N 232 232 
Visual acuity Pearson Correlation -,175
**
 1 
Sig. (1-tailed) ,004  
N 232 232 
**. Correlation is significant at the 0.01 level (1-tailed). 
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Correlations 
   Morphological 
stages of iris 
pathology Visual acuity 
Spearman's rho Morphological degrees of iris 
pathology 
Correlation Coefficient 1,000 -,193
**
 
Sig. (1-tailed) . ,002 
N 232 232 
Visual acuity Correlation Coefficient -,193
**
 1,000 
Sig. (1-tailed) ,002 . 
N 232 232 
**. Correlation is significant at the 0.01 level (1-tailed). 
 
 
 
Figure 5.7: Correlation of visual acuity and morphological degrees of iris pathology age 
group 6-15, test group with EI, n = 232. Age group 6-15 Degree 1-4 pSW < 0.05. Skewness 
Degree 1 = 3.28, Degree 2 = 3.46, Degree 3 = 7.71, Degree 4 = 9.02. Kurtosis Degree 1 = 
1.65, Degree 2 = 0.96, Degree 3 = 8.4, Degree 4 = 13.77. 
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Indeed, the dramatic impact of iris morphology on vision is also found in the control group. 
As shown in Figure 5.8, there is a statically significant decrease in visual acuity with an 
increase in iris pathology. Here, the Spearman’s rho correlation coefficient is -0.244 and 
the significance is 0.002. It must be noted, however, that the data in Figure 5.8 should, 
strictly speaking, be analysed using the Pearson algorithm (pSW > 0.05). Here, a similar 
trend is observed. The Pearson correlation is also negative, at -0.305, with a significance 
of 0.000. Hence regardless of the algorithm used, the notion that the visual acuity is 
reduced significantly with an increasing degree of iris morphology holds true for both 
cohorts, the test group of children aged 6-15 and the control group aged 25+. 
 
Correlations 
  
Visual acuity 
Morphological degrees  of iris 
pathology 
Visual acuity Pearson Correlation 1 -,305
**
 
Sig. (1-tailed)  ,000 
N 139 139 
Morphological degrees  of iris 
pathology 
Pearson Correlation -,305
**
 1 
Sig. (1-tailed) ,000  
N 139 139 
**. Correlation is significant at the 0.01 level (1-tailed). 
 
Correlations 
   
Visual acuity 
Morphological 
degrees  of iris 
pathology 
Spearman's rho Visual acuity Correlation Coefficient 1,000 -,244
**
 
Sig. (1-tailed) . ,002 
N 139 139 
Morphological degrees  of iris 
pathology 
Correlation Coefficient -,244
**
 1,000 
Sig. (1-tailed) ,002 . 
N 139 139 
**. Correlation is significant at the 0.01 level (1-tailed). 
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Figure 5.8: Correlation of visual acuity and morphological degrees of iris pathology Age 
group 25+, control group , n = 139. Age group 25+ Degree 1-2 pSW > 0.05, Degree 3-4 
p<0.05. Skewness Degree 1 = - 0.21, Degree 2 = 0, Degree 3 = 4.4, Degree 4 = 5.6. 
Kurtosis Degree 1 = -1.31, Degree 2 = - 1.11, Degree 3 = 0.87 Degree 4 = 4.94. 
 
 
5.5.2. Visual Acuity and Macular Pathomorphology 
 
The notion that morphological features ultimately determine the visual acuity of patients, 
and by far outpace any small effects due to Early Intervention, is supported further when 
considering other morphological parameters besides iris pathology, such as the 
morphological degrees of macular pathology. As Figure 5.9 indicates, the correlation 
between visual acuity and the morphological degrees of macular pathology in the test 
group is statistically significant, whereby the Spearman’s rho correlation coefficient in this 
case is -0.146 with a significance level of 0.013, implying that visual acuity is related 
inversely to an increase in the degree of macular pathology. 
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Correlations 
  
Visual acuity 
Morphological degrees of macular 
pathology 
Visual acuity Pearson Correlation 1 -,145
*
 
Sig. (1-tailed)  ,014 
N 232 232 
 Morphological  degrees of  
of macular pathology 
Pearson Correlation -,145
*
 1 
Sig. (1-tailed) ,014  
N 232 232 
*. Correlation is significant at the 0.05 level (1-tailed). 
 
Correlations 
   
Visual acuity 
Morphological 
degrees of 
macular 
pathology 
Spearman's rho Visual acuity Correlation Coefficient 1,000 -,146
*
 
Sig. (1-tailed) . ,013 
N 232 232 
Morphological degrees of 
macular pathology 
Correlation Coefficient -,146
*
 1,000 
Sig. (1-tailed) ,013 . 
N 232 232 
*. Correlation is significant at the 0.05 level (1-tailed) 
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Figure 5.9: Correlation of visual acuity and morphological degrees of macular pathology 
Age group 6-15, test group, n = 232. Age group 6-15 Degree 1-4 pSW < 0.05. Skewness 
Degree 1 = 3.07, Degree 2 = 5.42, Degree 3 = 6.77, Degree 4 = 6.39. Kurtosis Degree 1 = 
- 0.02, Degree 2 = 8.6 Degree 3 = 6.92 Degree 4 = 5.43 
 
As in the case of iris pathology, the impact of macular pathology on visual acuity is 
independent of the cohort used, as a similar trend is also observed in the control group 
shown in Figure 5.10. Here, the correlation between a lower visual acuity and a higher 
degree of macular pathology is also statistically significant, with a Spearman’s rho 
correlation coefficient of -0.216 and a significance of 0.005. 
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Correlations 
  
Visual acuity 
 Morphological degrees  of 
macular pathology 
Visual acuity Pearson Correlation 1 -,142
*
 
Sig. (1-tailed)  ,048 
N 139 139 
 Morphological degrees  of 
macular pathology 
Pearson Correlation -,142
*
 1 
Sig. (1-tailed) ,048  
N 139 139 
*. Correlation is significant at the 0.05 level (1-tailed). 
 
 
Correlations 
   
Visual acuity 
 Morphological degrees  
of macular pathology 
Spearman's rho Visual acuity Correlation Coefficient 1,000 -,216
**
 
Sig. (1-tailed) . ,005 
N 139 139 
 Morphological degrees  of 
macular pathology 
Correlation Coefficient -,216
**
 1,000 
Sig. (1-tailed) ,005 . 
N 139 139 
**. Correlation is significant at the 0.01 level (1-tailed). 
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Figure 5.10: Correlation of visual acuity and morphological degrees of macular pathology 
Age group 25+, control group, n = 139. Age group 25+ Degree 1-4 pSW < 0.05. Skewness 
Degree 1 = 2.72, Degree 2 = 2.69, Degree 3 = 3.31, Degree 4 = 7.14. Kurtosis Degree 1 = 
0.97, Degree 2 = 1.35 Degree 3 = 0.3 Degree 4 = 8.21. 
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5.5.3. Visual Acuity and Optic Nerve Head Pathology 
 
There are other pathologies, however, which compared to iris pathology and macular 
pathology, seem to be less significantly correlated with visual acuity. Here, the 
morphological degrees of optic nerve pathology have been considered first. Figure 5.11 
indicates that in the test group, the degree of optical nerve pathology indeed correlates 
with a (lower) visual acuity, yet the statistical significances are lower than in the cases 
described above. As expected, the Spearman’s rho correlation coefficient is -0.060, yet 
with a significance of just 0.181. A similar correlation is also found in the control group, 
which – in a strict sense has to be analysed employing the Pearson algorithm (pSW > 
0.005). As shown in Figure 5.12, this correlation is statistically significant. The Pearson 
correlation is -0.163 with a significance of 0.028. Merely for comparison, the Spearman’s 
rho correlation coefficient for this correlation, if applicable, would also be similarly 
negative, at -0.186, with a significance of 0.014. 
 
Correlations 
  
Visual acuity 
Morphological degrees of 
optic nerve pathology 
Visual acuity Pearson Correlation 1 -,117
*
 
Sig. (1-tailed)  ,037 
N 232 232 
Morphological degrees of 
optic nerve pathology 
Pearson Correlation -,117
*
 1 
Sig. (1-tailed) ,037  
N 232 232 
*. Correlation is significant at the 0.05 level (1-tailed). 
 
Correlations 
   
Visual acuity 
Morphological 
degrees of optic 
nerve pathology 
Spearman's rho Visual acuity Correlation Coefficient 1,000 -,060 
Sig. (1-tailed) . ,181 
N 232 232 
Morphological degrees of 
optic nerve pathology 
Correlation Coefficient -,060 1,000 
Sig. (1-tailed) ,181 . 
N 232 232 
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Figure 5.11: Correlation of visual acuity and morphological degrees of optic nerve 
pathology Age group 6-15, test group, n = 232. Age group 6-15 Degree 1-4 pSW < 0.05. 
Skewness Degree 0 = 2.45 Degree 1 = 6.11, Degree 2 = 3.68, Degree 3 = 6.53, Degree 4 
= 6.86. Kurtosis  Degree 0 = 2.5 Degree 1 = 7.21, Degree 2 = 2.19 Degree 3 = 5.85 
Degree 4 = 7.56. 
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Correlations 
  
Visual acuity 
Morphological  degrees of optic 
nerve pathology  
Visual acuity Pearson Correlation 1 -,163
*
 
Sig. (1-tailed)  ,028 
N 139 139 
Morphological  degrees of 
optic nerve pathology  
Pearson Correlation -,163
*
 1 
Sig. (1-tailed) ,028  
N 139 139 
*. Correlation is significant at the 0.05 level (1-tailed). 
 
Correlations 
   Morphological  
degrees of optic 
nerve pathology  Visual acuity 
Spearman's rho Morphological  degrees of 
optic nerve pathology  
Correlation Coefficient 1,000 -,186
*
 
Sig. (1-tailed) . ,014 
N 139 139 
Visual acuity Correlation Coefficient -,186
*
 1,000 
Sig. (1-tailed) ,014 . 
N 139 139 
*. Correlation is significant at the 0.05 level (1-tailed). 
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Figure 5.12: Correlation of visual acuity and morphological degrees of optic nerve 
pathology Age group 25+, control group, n = 139. Age group 25+ Degree 0 pSW > 0.05, 
Degree 1-4 Skewness Degree 0 = -1.12 Degree 1 = 3.71, Degree 2 = 4.3, Degree 3 = 
2.66, Degree 4 = 6.15. Kurtosis Degree 0 = 0.41 Degree 1 = 2.08, Degree 2 = 4.42 
Degree 3 = 1.08 Degree 4 = 4.84 
 
 
5.5.4. Visual Acuity and Strabismus 
 
Finally, a possible correlation between visual acuity and squint has also been considered. 
Unlike the pathologies analysed before, squint is not a “pathology” in the sense of a 
particular degeneration (e.g. of iris, macular, optical nerve), but caused by an incorrect 
positioning of the optical axis (see section 1). Hence when it comes to persons with 
albinism, it is necessary to distinguish between different groups of patients. One group of 
patients has no squint. There are two groups with Strabismus convergens and Strabismus 
divergens, respectively, whilst the fourth group doesn’t have any defined data on squint in 
the relevant patient’s records. One may speculate that there is a correlation between 
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visual acuity and squint and that such a correlation may become apparent during 
statistical analysis. 
 
The data for the test group is shown in Figure 5.13. At first inspection, there seems to be 
a decrease in the median visual acuity from around 0.3 in persons without squint to 
around 0.15 to 0.2 in persons with Strabismus convergens and Strabismus divergens. 
Such a correlation, however, is not statistically significant. Whilst the Spearman’s rho 
correlation coefficient is negative with a value of -0.058, as may be expected, the 
significance is 0.379. A similar trend is found in the control group as illustrated in Figure 
5.14. Here, a similar, negative correlation is found between visual acuity and different 
types of squint. As in the test group, the Spearman’s rho correlation coefficient is negative, 
at -0.046, yet with a low significance of 0.590. 
 
Correlations 
  
Visual acuity 
Forms of squint associated 
with albinism 
Visual acuity Pearson Correlation 1 -,045 
Sig. (2-tailed)  ,491 
N 232 232 
Forms of squint associated 
with albinism 
Pearson Correlation -,045 1 
Sig. (2-tailed) ,491  
N 232 232 
 
Correlations 
   
Visual acuity 
Forms of squint 
associated with 
albinismus 
Spearman's rho Visual acuity Correlation Coefficient 1,000 -,058 
Sig. (2-tailed) . ,379 
N 232 232 
Forms of squint associated 
with albinismus 
Correlation Coefficient -,058 1,000 
Sig. (2-tailed) ,379 . 
N 232 232 
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Figure 5.13: Correlation of visual acuity and forms of squint associated with albinism age 
group 6-15, test group, n = 232. Age group 6-15 Degree 1-4 pSW < 0.05. Skewness No 
squint 2.53, Strabismus convergens 8.75, Strabismus divergens 6.17, Not defined 3.25. 
Kurtosis No squint 0.81, Strabismus convergens 8.12, Strabismus divergens 8.05, Not 
defined 1.28. 
 
The general trend observed in the test group of children aged 6-15 is confirmed in the 
group of adults aged 25+. As illustrated in Figure 5.14, strabismus seems to be related to 
a decreased visual acuity, yet these changes are once more not statistically significant 
with a significance of just 0.590. 
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Correlations 
  
Visual acuity 
Forms of squint associated with 
albinism 
Visual acuity Pearson Correlation 1 -,077 
Sig. (2-tailed)  ,370 
N 139 139 
Forms of squint associated 
with albinism 
Pearson Correlation -,077 1 
Sig. (2-tailed) ,370  
N 139 139 
 
   
Visual acuity 
Forms of squint 
associated with 
albinismus 
Spearman's rho Visual acuity Correlation Coefficient 1,000 -,046 
Sig. (2-tailed) . ,590 
N 139 139 
Forms of squint associated 
with albinismus 
Correlation Coefficient -,046 1,000 
Sig. (2-tailed) ,590 . 
N 139 139 
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Figure 5.14: Correlation of visual acuity and forms of squint associated with albinism Age 
group 25+, control group, n = 139. Age group 25+ Degree 1-4 pSW < 0.05. Skewness No 
squint 2.26, Strabismus convergens 4.84 Strabismus divergens 4.6, Not defined 2.53. 
Kurtosis No squint 0.29, Strabismus convergens 2.34, Strabismus divergens 2.21, Not 
defined 1.08. 
 
  
Early Intervention in Albinism 
67 
6. Discussion 
 
Overall, the results obtained as part of this study point towards a small and statistically not 
significant improvement of visual acuity in females who have received Early Intervention. 
Whilst this improvement is not due to any significant differences in the pathologies 
underlying the test and control groups, it is also weak and cannot overcome the various 
iris, macular and optical nerve pathologies which ultimately correlate with visual acuity, 
regardless if Early Intervention has been applied or not. 
 
 
6.1. General impact of EI on visual acuity 
 
As the primary objective of this study has been a direct comparison of patients with 
albinism who have - and have not - undergone EI, it has been essential to ensure upfront 
that both cohorts (one with, one without EI) do not differ significantly in any other relevant 
parameters, such as a particular morphology. As shown in Figure 5.1, the Optic Nerve 
Head is morphologically and anatomically identical in test and control groups. If this were 
not the case, it would be futile to statistically compare the impact of Early Intervention. 
 
Backed with this pivotal information, it has then be possible to compare the two cohorts in 
question, i.e. the children aged 6-15 who had undergone EI with the control group of 
adults aged 25+ who because of their age had not been exposed to EI during their 
childhood. The results shown in Figure 5.2 indicate that there may be a slight tendency to 
an improved visual acuity in the children with EI, but this “improvement” - if at all - is 
statistically not significant. Whilst this particular outcome is rather disappointing from a 
therapeutic point of view, the numbers shown in Figure 5.2. also provide one additional 
information: The visual acuity in both groups is extraordinarily low, i.e. around 0.2, whilst a 
normal visual acuity is around 1.0. This finding is relevant as it indicates that the patients 
in question have a very low visual acuity, which must be caused by serious morphological 
“defects”. In turn, such “defects”, which have been investigated and will be discussed in 
more detail later on, are obviously difficult to treat by non-invasive measures, such as EI. 
Hence it may not be that surprising that (a) the visual acuity is extremely low in both 
groups and (b) any milder form of intervention may not suffice to address the serious 
disorders at the root of this very low visual acuity. This discussion will be revisited when 
considering such morphological changes (see from Figures 5.7 to 5.12). 
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6.2. Gender-specific effects 
 
Returning to the more general view on visual acuity and EI, it is interesting to note the 
difference which exists between female and male patients. As mentioned in the Results 
section, there is a slight improvement of visual acuity in females who have received Early 
Intervention (Figure 5.3). Whilst this improvement is statistically not significant, the trend 
is clearly visible, especially when compared to the male counterparts. Here, a small, but 
insignificant trend in the opposite direction may be perceived, whereby the control group 
of patients aged 25+ even appears to have a better visual acuity (Figure 5.4). Whilst this 
effect is minor and not worth discussing further, it confirms that there is certainly no trend 
towards an improved visual acuity in the case of males. 
 
It seems that if Early Intervention is probably more effective in girls than boys. Whilst this 
improvement in visual acuity is comparably modest (around 0.1 at most) and also not 
seen in all participants (hence a low statistical significance), it still represents a non-
invasive kind of treatment and deserves serious consideration in the future. 
 
In order to obtain a better insight into this gender-specific effect, a few additional analyses 
have been carried out. As the findings shown in Figure 5.3 consider two variables, namely 
EI and sex, the possibility that women generally have a better visual acuity than men has 
been investigated, as this may also explain the findings seen in Figure 5.3 and Figure 
5.4. As Figure 5.5 illustrates nicely, this does not seem to be the case. If any trend is 
noticed in this figure, then it is a rather worse general visual acuity in females with 
albinism compared to males with albinism. Whilst a significance of 0.166 is not relevant, it 
is rather good and refutes the hypothesis that albinistic women in general may show a 
better visual acuity than albinistic men. Hence the improvement in visual acuity seen for 
girls with EI, but not for boys with EI, is not due to their gender but probably indeed to EI. 
This explanation is supported by the box plots in Figure 5.6. Here, the apparent 
improvement of visual acuity in girls (with EI) compared to boys (with EI) is visible once 
more. In the case of patients with EI, the dependence on gender is opposite compared to 
the patients without EI, hence counting against sex as the decisive factor and confirming 
that EI may indeed result in some improvements in visual acuity, especially - if not 
exclusively - in girls. 
 
Here, the statistical methods employed as part of this study reach their own limitations, as 
they are used to analyse differences between cohorts, and cannot focus on changes on 
an individual basis. Indeed, some individual patients may benefit considerably from EI. It 
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seems that visual acuity of individual participants “hidden” behind the boxes of the plot is 
generally better in the females of the test group. Whilst the form of the box plots shows 
that the values of visual acuity are rather spread in females and males, with and without 
EI, the highest value for the spread of visual acuity in girls with EI is 0.8 whereas in the 
control group it is 0.5 (Figure 5.3). The data are almost opposite in the males in test and 
control groups (Figure 5.4). Although no firm conclusions can be based on these spreads, 
they may indicate that some of the girls with EI ultimately have a visual acuity which is 
considerably improved compared to the “baseline” of around 0.2, and in some cases even 
reaches values close to normal. 
 
In the future, questions if EI is beneficial to girls and / or boys, if significant improvements 
of visual acuity by more than just 0.1 units can be achieved by this method, and if the key 
to a successful treatment with EI is a particular genetic predisposition or due to a 
particular morphology, need to be addressed on an individual basis (see also section 
6.5.). Such studies would be rather extensive and, for instance, monitor the success of EI 
on the basis of individual patients and over the duration of many years. They may be 
rather difficult to execute, though, as appropriate “control” patients would probably be hard 
to find, assuming that EI is now used widely in Germany. 
 
 
6.3. The overarching role of morphological changes 
 
Whilst the previous discussion has focussed on the role of EI in - a possible improvement 
of - visual acuity, the trends seen in response to EI, if any, were minor and not particularly 
relevant from a statistical point of view. As described at length in the Introduction, patients 
affected by albinism exhibit a range of serious ophthalmic impediments, which in one way 
or another may result in a dramatically reduced visual acuity. Such impediments include 
various morphological changes affecting the eye and ultimately may “dominate” the 
patient’s eyesight, rendering a milder form of intervention, such as EI, almost ineffective. 
 
It has therefore been important to establish some of these “predominant” factors in the 
patients who have undergone EI and the patients of control group, to see if any of these 
factors, in particular, may promote or prevent the effectiveness of EI. 
 
It is already known, for instance, that the impact of iris morphology on visual acuity in 
patients with albinism is less in comparison to optic nerve head and macular pathology 
(Käsmann-Kellner 2000). At the same time, hypopigmentation of the iris does not seem to 
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primarily affect visual acuity but rather causes a kind of glare. 
 
As can be seen in Figure 5.7 and Figure 5.8, the visual acuity, however, correlates highly 
significantly with the morphological degree of iris pathology in the test as well as in the 
control group. As expected, the more limited the changes of the iris morphology are (i.e. 
degree 1), the better is the visual acuity and vice versa. This correlation is immediately 
apparent in the age group 25+ but also holds true for the children treated with EI. It is 
noteworthy that the median of visual acuity in the control group with a degree 1 even 
exceeds 0.5, but the spread is rather large in this case. At the same time, none of the 
patient cohorts, regardless of the degree of iris pathology, shows a visual acuity close to 
normal. This underlines once more that regardless of its severity, the pathology of the iris 
reduces visual acuity. It is then hardly surprising that a mild form of treatment, such as EI, 
cannot perform “miracles” by restoring visual acuity from a value close to 0.2. or 0.3 all the 
way to normal. 
 
Similar considerations apply to the correlation of the visual acuity with the morphological 
degree of macular pathology. As shown in test and control groups Figure 5.9 and 
Figure 5.10, all patients involved, regardless of EI or not, or of the specific degree of 
macular pathology, exhibit a drastically reduced visual acuity of around or even below 0.2. 
As for the iris, the degree of pathology seems to correlate inversely with the visual acuity, 
which is hardly surprising as a worse pathology should also result in a worse visual acuity. 
Whilst this trend is interesting from a statistic point of view - these are (highly) significant 
correlations - it is less thrilling from an ophthalmological perspective. Even patients with a 
degree 1 of macular pathology show a very poor visual acuity, and therefore the 
correlations observed, and any small differences which might exist depending on the 
degree of the pathology or EI are minute when projected on the overall scale of visual 
acuity which reaches to 1.0 as normal. 
 
In essence, the same applies to considerations involving the morphological degree of 
optic nerve head pathology. As is apparent from the data presented in Figure 5.11 and 
Figure 5.12, there is a clear inverse correlation between the degree of pathology and 
visual acuity in both, the group of children with EI and the control group of patients aged 
25+. It should be noted that in this particular case, patients with a “degree 0” have been 
available in both cohorts and hence a benchmark value for the visual acuity of those 
patients could be determined. As may be expected, a degree 0 (normal optic nerve head) 
is associated with a rather good visual acuity of around 0.8 in the control group and 
around 0.7 in the group of children with EI. In contrast, patients with a degree of 1 or 
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higher show a dramatically reduced visual acuity of around 0.2. Since the overall sizes of 
sub-groups are fairly small, these numbers for the means, and the general correlations 
shown in the two figures need to be taken with some care. Yet they still corroborate the 
general conclusion that pathologies are the overriding factors when it comes to visual 
acuity, and that EI can only result in small, statistically insignificant improvements - at least 
when entire populations rather than individuals are considered. 
 
Overall, the various correlations seen in Figure 5.7 to Figure 5.12 between pathologies 
on the one hand and visual acuity on the other seem to be fairly plausible from a medical 
perspective and, as mentioned already, support the notion that pathologies ultimately form 
the overarching determinants of visual acuity. Indeed, this notion is not new, and as 
mentioned above, Käsmann-Kellner et al. have already discussed the fact that the better 
the macula and Optic Nerve Head morphology are, the better their function is (Käsmann-
Kellner et al. 2007). Whilst the results obtained in the present study in essence confirm 
these previous findings and trends, for instance with regard to the iris, optic nerve head 
and macular pathology, there are also slight differences. 
 
 
6.4. Squint 
 
The two forms of squint, i.e. Strabismus convergens and Strabismus divergens are 
associated with albinism (Käsmann-Kellner et al. 2007). Furthermore, the visual acuity 
could be affected by both forms of squint, as both of them may lead to amblyopia. As 
shown in Figure 5.13, the mean visual acuity in children with no squint appears to be 
slightly higher when compared to the children with squint (just above 0.3 compared to 
between 0.1 and 0.2, respectively). In contrast, no apparent impact of squint on an 
already poor visual acuity can be observed in the case of the control group of adults aged 
25+ (Figure 5.14). In this group the visual acuity is again centred around a median of 
between 0.1 and 0.2 in patients with or without squint. Indeed, in all cases any changes 
that may be related to squint are not statistically significant and, from an ophthalmological 
perspective, certainly minor on a scale from 0 to 1. 
 
Whilst a major impact of pathologies, such as macular and optical nerve pathologies, on 
visual acuity is hardly surprising, these findings also deserve some comment from a more 
medical perspective. Considering the data and the various correlations and significances 
at hand, it appears, for instance, that a hypopigmentation of iris or dysplasia of macula 
and optic nerve head results in an - often severely - reduced visual acuity. Moreover, iris 
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morphology seems to contribute the least to visual acuity when compared with the two 
other pathologies, in agreement with previous findings (Käsmann-Kellner 2000, see 
above). Yet these numbers need to be used with some caution. Whilst a statistical 
analysis may indeed point towards a significant correlation between two parameters, the 
latter may not necessarily form a causal relationship, but may both represent 
consequences of a third, perhaps yet unknown parameter. Whilst it is therefore safe to 
state that all three, i.e. iris pathology, macular pathology and optic nerve pathology 
represent parameters which allow a prediction of visual acuity (in these cases the more 
advanced the pathology, the worse the visual acuity), such low visual acuity it is not 
necessary caused directly by either of these pathologies. This is sensible as it is indeed 
unlikely that these pathologies, act on their own and that each pathology results in an 
isolated effect on visual acuity which can then simply be “added to the total”. Albinism, 
loss of pigmentation and the various complex biochemical and physiological processes 
associated with such disturbances may manifest themselves in many different ophthalmic 
pathologies and problems, and not just in one pathology. There may well be additional 
factors further compromising visual acuity, which may be considered as independent, 
“additional burdens”, for instance glaucoma and maybe squint. Unfortunately, as in the 
case of squint, the data sets available in this study are insufficient to demonstrate such a 
purely “additional” effect which may be causally unrelated to the other pathologies and 
hence could be treated separately. 
 
Ultimately, the correlations discussed here are purely “mathematical” and do not provide 
any information about the (anatomical, biochemical) mechanisms which may link these 
pathologies to visual acuity and ultimately establish a true causal relationship. Here 
statistics needs to move on into the realm of (bio)medicine in order to literally fill the 
numbers with life. 
 
 
6.5. Is Early Intervention a women’s thing - and why? 
 
These issues need to be born in mind when moving on to the question if EI itself has an 
impact on visual acuity. As above, any correlations seen in this case may be due to a 
direct causal relationship, or the consequence of a third parameter impacting at the same 
time on both parameters. And indeed, whilst it appears that EI overall results only in a 
rather limited improvement of visual acuity, the effect seems to differ once a further 
parameter, i.e. gender, is also taken into account. As shown in Figures 5.3 and 5.4, there 
is a slight, noticeable but still statistically insignificant improvement of visual acuity in 
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females, but not in males, who have undergone EI. This apparent improvement may have 
been due to a generally better visual acuity among females, yet this gender specific 
advantage has been ruled out by comparing females and males in the test and control 
groups in Figures 5.5 and 5.6. The improvement of visual acuity is comparably modest 
(around 0.1 at most) and also not seen in all participants (hence a low statistical 
significance). Still EI represents a non-invasive kind of treatment and deserves serious 
consideration in the future. 
 
At the same time, the underlying causes of the notable differences between females and 
males need to be considered. As delineated above, the statistical analysis does not 
answer the question why such effects may occur. It may be possible, for instance, that 
girls of this particular age (6 to 15) are more compliant with EI than boys. It may also be 
possible that the causes at the root of low visual acuity are somewhat different in girls and 
boys (see Introduction) and hence girls do respond better to such “treatment” when 
compared to boys. 
 
Moreover, it would be counter-productive to suggest that EI only “works” in females and 
males may not benefit from this treatment at all. Indeed, EI not only - more or less - affects 
visual acuity, but also assists in the development of diverse compensatory mechanisms. 
This in turn may or may not lead to a notably improved visual acuity in later life. Ultimately, 
the matter at hand is far from trivial, as visual acuity is just one of a wide range of 
parameters influenced by EI. 
 
In the end, the statistical analysis performed as part of this study can only highlight some 
significant - and not so significant - correlations and trends, but cannot explain the 
underlying causes. Here, more eloquent studies will be required to determine the impact 
of EI on fully “characterized” individual patients, including relevant genetic information. 
These patients would have to be monitored throughout the time of EI and the years 
afterwards. 
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7. Conclusions and outlook 
 
To conclude, the statistical analysis conducted as part of this thesis points towards a slight 
yet statistically insignificant improvement of visual acuity in females who have undergone 
EI. This even slight improvement of around 0.1 visual units is notably absent in males. As 
the cohorts used in this study are rather large, a coincidental trend is less likely. It rather 
appears that females seem indeed to benefit more from EI than males. 
 
In the future, it would therefore be interesting to study in more detail why EI may be more 
effective in girls than in boys. At this point, one may speculate that either genetic causes 
or a better compliance could affect the ultimate outcome. It may be possible, for instance, 
that girls of infantile age (0 to 6) are more compliant with EI than boys. In this case, the 
results ultimately achieved by this approach may be better in girls than in boys. 
 
In the future, these issues could be investigated as part of a new study which would not 
simply rely on “old”, “passive” data of entire patient populations, but would accompany 
and closely monitor the EI process on an individual basis, for instance by recording the 
number of sessions, the effort of the children and also other factors which may influence 
the outcome. As part of the follow-on process after completion of EI, visual acuity of the 
patients should be tested regularly and over a longer period of time. Using this rather 
tedious and time-consuming approach, it would then be possible to draw firm conclusions 
about any improvements within the same cohort of patients and possibly also to identify 
the factors influencing or enhancing any such improvements. 
 
From a research point of view, possible genetic influences are also of considerable 
interest. It may be possible that the causes at the root of low visual acuity are somewhat 
different in girls and boys (see Introduction) and hence girls do respond better to such 
“treatment” when compared to boys. Indeed, this idea has been considered as part of the 
present study, but as all pathologies caused a dramatic reduction in visual acuity, a more 
refined analysis has not been possible. This hypothesis is not too far-fetched, as various 
forms of albinism are X-chromosome linked. Here, the participants of this study would 
have to be dissected further into sub-groups based on specific forms of albinism. 
Information on these underlying causes may ultimately enhance or refine treatment, and 
at the same time may also serve as a predictor for the outcome of such a treatment. 
 
Ultimately, it may even be possible to perform an entirely new study using genetic 
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information in addition to information about specific pathologies and visual acuity. Using 
techniques such as the Polymerase Chain Reaction (PCR); it is nowadays possible to 
obtain information on genetic mutations fairly rapidly, reliably and also rather 
inexpensively. It would therefore be very interesting to add the various genetic mutations, 
i.e. changes to melanin synthesis and transport as additional factor(s) to the study. Such a 
future investigation may also be complemented by an analysis of any anatomical 
processes and perhaps even biochemical mechanisms which may accompany EI “on the 
quiet” and hence result in an improved visual acuity. 
 
In any case, whilst this study has shown that pathologies such as the morphological 
pathology of the macula and the optical nerve are clearly the predominant factors 
influencing visual acuity in the patients, it has also lent some additional support to the idea 
that EI is not a miracle cure but ultimately may make at least some sense, especially in 
girls - and that this form of mild, non-invasive treatment most certainly deserves further 
investigation. 
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